| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC3 ABCA3 BRIP1 NAIP KIF12 ATP8B1 LONP1 ATAD3C AFG3L2 ABCD1 DNAH8 HSPA2 DYNC1H1 DYNC2H1 ABCC5 RNF213 ABCG1 SLFN13 HELZ2 ABCB11 SLFN11 POLQ ATP2B1 SMC1B | 8.34e-09 | 441 | 270 | 24 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC3 ABCA3 BRIP1 SETX NAIP KIF12 ATP8B1 LONP1 ATAD3C AFG3L2 ABCD1 DNAH8 HSPA2 DYNC1H1 DNHD1 APPBP2 DYNC2H1 ABCC5 RNF213 ABCG1 SLFN13 HELZ2 ABCB11 SLFN11 POLQ ATP2B1 SMC1B | 8.18e-08 | 614 | 270 | 27 | GO:0140657 |
| GeneOntologyMolecularFunction | ATPase-coupled lipid transmembrane transporter activity | 3.91e-06 | 9 | 270 | 4 | GO:0034040 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCC3 ABCA3 BRIP1 NAIP KIF12 ATP8B1 AGAP11 LONP1 ATAD3C AFG3L2 ABCD1 DNAH8 HSPA2 DYNC1H1 DYNC2H1 ABCC5 RNF213 ABCG1 SLFN13 HELZ2 ABCB11 SLFN11 POLQ ATP2B1 DIRAS2 SMC1B | 2.04e-05 | 775 | 270 | 26 | GO:0017111 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GABRP UNC5B GPR182 ADGRB1 ADGRB2 ADGRB3 GPR135 TAS2R38 OR2B6 PLXNB2 UNC5A MET PTPRB HMCN2 PKD1 OR1K1 NMBR CHRNA10 OR10S1 PLXNB1 OR8J3 FLT3 HTR1B GPR22 GALR3 OR2A5 OR8U3 GRM6 CCKAR ADGRG6 P2RY6 TAS2R33 TLR5 ADGRE5 ADGRD2 HCRTR2 HRH3 | 3.41e-05 | 1353 | 270 | 37 | GO:0004888 |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 3.97e-05 | 15 | 270 | 4 | GO:0008559 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | PKD1L2 RYR2 RYR3 ITPR1 CACNG2 PKD1 CHRNA10 HTR1B CACNG4 ATP2B1 | 4.07e-05 | 151 | 270 | 10 | GO:0015085 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 4.96e-05 | 49 | 270 | 6 | GO:0140359 | |
| GeneOntologyMolecularFunction | calcium channel activity | 6.60e-05 | 129 | 270 | 9 | GO:0005262 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | PKD1L2 ASIC3 SLC30A3 RYR2 RYR3 ITPR1 CACNG2 PKD1 SCN9A KCNK2 CHRNA10 SLC4A9 HTR1B HCN3 LRRC52 SLC39A12 CACNG4 ATP2B1 | 6.81e-05 | 465 | 270 | 18 | GO:0046873 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCC3 ABCA3 BRIP1 NAIP KIF12 ATP8B1 AGAP11 LONP1 ATAD3C AFG3L2 ABCD1 DNAH8 HSPA2 DYNC1H1 DYNC2H1 ABCC5 RNF213 ABCG1 SLFN13 HELZ2 ABCB11 SLFN11 POLQ ATP2B1 DIRAS2 SMC1B | 7.68e-05 | 839 | 270 | 26 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCC3 ABCA3 BRIP1 NAIP KIF12 ATP8B1 AGAP11 LONP1 ATAD3C AFG3L2 ABCD1 DNAH8 HSPA2 DYNC1H1 DYNC2H1 ABCC5 RNF213 ABCG1 SLFN13 HELZ2 ABCB11 SLFN11 POLQ ATP2B1 DIRAS2 SMC1B | 7.83e-05 | 840 | 270 | 26 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCC3 ABCA3 BRIP1 NAIP KIF12 ATP8B1 AGAP11 LONP1 ATAD3C AFG3L2 ABCD1 DNAH8 HSPA2 DYNC1H1 DYNC2H1 ABCC5 RNF213 ABCG1 SLFN13 HELZ2 ABCB11 SLFN11 POLQ ATP2B1 DIRAS2 SMC1B | 7.83e-05 | 840 | 270 | 26 | GO:0016818 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 8.62e-05 | 18 | 270 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | PKD1L2 ASIC3 RYR2 RYR3 ITPR1 CACNG2 PKD1 SCN9A KCNK2 CHRNA10 HTR1B HCN3 LRRC52 CACNG4 | 2.56e-04 | 343 | 270 | 14 | GO:0005261 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRP ABCC3 PKD1L2 ASIC3 SLC30A3 RYR2 RYR3 ITPR1 CACNG2 PKD1 SCN9A KCNK2 CHRNA10 SLC4A9 HTR1B HCN3 ABCC5 ADAMTS8 LRRC52 SLC39A12 BEST4 CACNG4 ATP2B1 | 2.72e-04 | 758 | 270 | 23 | GO:0015318 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRP ABCC3 ABCA3 CEACAM5 SLCO4A1 PKD1L2 ASIC3 SLC30A3 SLC66A1 RYR2 RYR3 ITPR1 CACNG2 SLC35A2 PKD1 SCN9A KCNK2 ABCD1 CHRNA10 SLC4A9 HTR1B HCN3 ABCC5 ADAMTS8 LRRC52 SLC39A12 ABCG1 BEST4 ABCB11 CACNG4 ATP2B1 | 3.13e-04 | 1180 | 270 | 31 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | GABRP ABCC3 ABCA3 CEACAM5 SLCO4A1 ATP8B1 PKD1L2 ASIC3 SLC30A3 SLC66A1 RYR2 RYR3 ITPR1 CACNG2 SLC35A2 PKD1 SCN9A KCNK2 ABCD1 CHRNA10 SLC4A9 PLEKHA8 HTR1B HCN3 ABCC5 ADAMTS8 LRRC52 SLC39A12 ABCG1 BEST4 ABCB11 CACNG4 ATP2B1 | 3.16e-04 | 1289 | 270 | 33 | GO:0005215 |
| GeneOntologyMolecularFunction | microtubule motor activity | 3.67e-04 | 70 | 270 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | GPR182 ADGRB1 ADGRB2 ADGRB3 GPR135 TAS2R38 OR2B6 OR1K1 NMBR OR10S1 OR8J3 HTR1B GPR22 GALR3 OR2A5 OR8U3 GRM6 CCKAR ADGRG6 P2RY6 TAS2R33 ADGRE5 ADGRD2 HCRTR2 HRH3 | 4.24e-04 | 884 | 270 | 25 | GO:0004930 |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 4.61e-04 | 73 | 270 | 6 | GO:0170055 | |
| GeneOntologyMolecularFunction | semaphorin receptor activity | 4.91e-04 | 12 | 270 | 3 | GO:0017154 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 5.18e-04 | 28 | 270 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | arginine-tRNA ligase activity | 5.42e-04 | 3 | 270 | 2 | GO:0004814 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GABRP PKD1L2 ASIC3 RYR2 RYR3 ITPR1 CACNG2 PKD1 SCN9A KCNK2 CHRNA10 HTR1B HCN3 LRRC52 BEST4 CACNG4 | 5.49e-04 | 459 | 270 | 16 | GO:0005216 |
| GeneOntologyMolecularFunction | gated channel activity | GABRP ASIC3 RYR2 RYR3 ITPR1 CACNG2 KCNK2 CHRNA10 HTR1B HCN3 LRRC52 BEST4 CACNG4 | 6.60e-04 | 334 | 270 | 13 | GO:0022836 |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 7.05e-04 | 109 | 270 | 7 | GO:0042626 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 9.82e-04 | 33 | 270 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | ABC-type bile acid transporter activity | 1.07e-03 | 4 | 270 | 2 | GO:0015432 | |
| GeneOntologyMolecularFunction | (d)CMP kinase activity | 1.07e-03 | 4 | 270 | 2 | GO:0004127 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 1.07e-03 | 4 | 270 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | ATPase-coupled organic acid transmembrane transporter activity | 1.07e-03 | 4 | 270 | 2 | GO:0033283 | |
| GeneOntologyMolecularFunction | ATPase-coupled monocarboxylic acid transmembrane transporter activity | 1.07e-03 | 4 | 270 | 2 | GO:0033285 | |
| GeneOntologyMolecularFunction | ATPase-coupled carboxylic acid transmembrane transporter activity | 1.07e-03 | 4 | 270 | 2 | GO:0033284 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 1.10e-03 | 34 | 270 | 4 | GO:0042910 | |
| GeneOntologyMolecularFunction | carbon-sulfur lyase activity | 1.20e-03 | 16 | 270 | 3 | GO:0016846 | |
| GeneOntologyMolecularFunction | lipid transporter activity | ABCC3 ABCA3 CEACAM5 SLCO4A1 ATP8B1 ABCD1 PLEKHA8 ABCG1 ABCB11 | 1.44e-03 | 196 | 270 | 9 | GO:0005319 |
| GeneOntologyMolecularFunction | calcium-dependent cysteine-type endopeptidase activity | 1.44e-03 | 17 | 270 | 3 | GO:0004198 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.52e-03 | 37 | 270 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.72e-03 | 18 | 270 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | channel activity | GABRP PKD1L2 ASIC3 RYR2 RYR3 ITPR1 CACNG2 PKD1 SCN9A KCNK2 CHRNA10 HTR1B HCN3 LRRC52 BEST4 CACNG4 | 2.21e-03 | 525 | 270 | 16 | GO:0015267 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | ABCC3 CEACAM5 SLCO4A1 ASIC3 SLC66A1 ABCD1 SLC4A9 ABCC5 SLC39A12 BEST4 ABCB11 | 2.24e-03 | 293 | 270 | 11 | GO:0008514 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GABRP PKD1L2 ASIC3 RYR2 RYR3 ITPR1 CACNG2 PKD1 SCN9A KCNK2 CHRNA10 HTR1B HCN3 LRRC52 BEST4 CACNG4 | 2.25e-03 | 526 | 270 | 16 | GO:0022803 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | PKD1L2 ASIC3 SLC30A3 RYR2 RYR3 ITPR1 CACNG2 PKD1 SCN9A KCNK2 CHRNA10 SLC4A9 HTR1B HCN3 LRRC52 SLC39A12 CACNG4 ATP2B1 | 2.30e-03 | 627 | 270 | 18 | GO:0022890 |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 2.35e-03 | 20 | 270 | 3 | GO:0035259 | |
| GeneOntologyMolecularFunction | phosphatidylcholine transporter activity | 2.35e-03 | 20 | 270 | 3 | GO:0008525 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 2.58e-03 | 70 | 270 | 5 | GO:1901618 | |
| GeneOntologyMolecularFunction | phosphatidylcholine flippase activity | 2.64e-03 | 6 | 270 | 2 | GO:0140345 | |
| GeneOntologyMolecularFunction | netrin receptor activity | 2.64e-03 | 6 | 270 | 2 | GO:0005042 | |
| GeneOntologyMolecularFunction | acetylesterase activity | 2.64e-03 | 6 | 270 | 2 | GO:0008126 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 2.64e-03 | 6 | 270 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | amine binding | 2.72e-03 | 21 | 270 | 3 | GO:0043176 | |
| GeneOntologyBiologicalProcess | xenobiotic transmembrane transport | 3.57e-06 | 19 | 268 | 5 | GO:0006855 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | GABRP ABCC3 SLCO4A1 ATP8B1 PKD1L2 ASIC3 SLC30A3 RYR2 RYR3 ITPR1 CACNG2 JAK3 PTPN3 AFG3L2 PKD1 SCN9A KCNK2 AHR CHRNA10 NOS1 HSPA2 UTRN SLC4A9 HTR1B HCN3 ABCC5 GRM6 CCKAR LRRC52 TG GRAMD2A SLC39A12 P2RY6 BEST4 CACNG4 ATP2B1 HRH3 | 2.02e-05 | 1374 | 268 | 37 | GO:0006811 |
| GeneOntologyBiologicalProcess | metal ion transport | PKD1L2 ASIC3 SLC30A3 RYR2 RYR3 ITPR1 CACNG2 JAK3 PTPN3 AFG3L2 PKD1 SCN9A KCNK2 AHR CHRNA10 NOS1 HSPA2 UTRN SLC4A9 HCN3 ABCC5 GRM6 CCKAR LRRC52 GRAMD2A SLC39A12 P2RY6 CACNG4 ATP2B1 | 4.70e-05 | 1000 | 268 | 29 | GO:0030001 |
| GeneOntologyBiologicalProcess | organic anion transport | EPRS1 ABCC3 CEACAM5 SLCO4A1 ATP8B1 ASIC3 SLC66A1 NFE2L1 SLC35A2 ABCD1 SLC4A9 PLEKHA8 HTR1B ABCC5 SHOC2 SLC39A12 BEST4 ABCB11 HRH3 | 4.79e-05 | 515 | 268 | 19 | GO:0015711 |
| GeneOntologyCellularComponent | calcium channel complex | 4.07e-05 | 73 | 267 | 7 | GO:0034704 | |
| GeneOntologyCellularComponent | cation channel complex | RYR2 RYR3 CACNG2 PKD1 SCN9A KCNK2 HSPA2 HCN3 LRRC52 CATSPERB CACNG4 | 2.31e-04 | 235 | 267 | 11 | GO:0034703 |
| GeneOntologyCellularComponent | basal part of cell | ABCC3 CEACAM5 NAIP SLCO4A1 ITGA1 ADCY8 MET PROM2 PKD1 SLC4A9 ABCC5 P2RY6 ABCB11 ATP2B1 | 3.86e-04 | 378 | 267 | 14 | GO:0045178 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | GABRP RYR2 RYR3 CACNG2 PKD1 SCN9A KCNK2 CHRNA10 HSPA2 HCN3 LRRC52 BEST4 CATSPERB CACNG4 | 3.86e-04 | 378 | 267 | 14 | GO:0034702 |
| Domain | AAA+_ATPase | ABCC3 ABCA3 NAIP LONP1 ATAD3C AFG3L2 ABCD1 DNAH8 DYNC1H1 DYNC2H1 ABCC5 RNF213 ABCG1 HELZ2 ABCB11 | 1.83e-09 | 144 | 262 | 15 | IPR003593 |
| Domain | AAA | ABCC3 ABCA3 NAIP LONP1 ATAD3C AFG3L2 ABCD1 DNAH8 DYNC1H1 DYNC2H1 ABCC5 RNF213 ABCG1 HELZ2 ABCB11 | 1.83e-09 | 144 | 262 | 15 | SM00382 |
| Domain | GPS | 1.78e-08 | 34 | 262 | 8 | SM00303 | |
| Domain | GPS | 2.29e-08 | 35 | 262 | 8 | PF01825 | |
| Domain | GPS | 2.90e-08 | 36 | 262 | 8 | PS50221 | |
| Domain | GPS | 3.66e-08 | 37 | 262 | 8 | IPR000203 | |
| Domain | - | ABCC3 NLRP12 TRIT1 ABCA3 BRIP1 SETX NAIP SLFN14 SRPRB AK7 NLRC4 LONP1 ATAD3C AFG3L2 ABCD1 DNAH8 DYNC1H1 DNHD1 DYNC2H1 ABCC5 RNF213 AK8 ORC5 ABCG1 SLFN13 HELZ2 ABCB11 SLFN11 POLQ DIRAS2 SMC1B | 6.76e-08 | 746 | 262 | 31 | 3.40.50.300 |
| Domain | P-loop_NTPase | ABCC3 NLRP12 TRIT1 ABCA3 BRIP1 SETX NAIP KIF12 SLFN14 SRPRB AK7 NLRC4 LONP1 ATAD3C AFG3L2 ABCD1 DNAH8 DYNC1H1 DNHD1 DYNC2H1 ABCC5 RNF213 AK8 ORC5 ABCG1 SLFN13 HELZ2 ABCB11 SLFN11 POLQ DIRAS2 SMC1B | 3.61e-07 | 848 | 262 | 32 | IPR027417 |
| Domain | GPCR_2_brain_angio_inhib | 2.73e-06 | 3 | 262 | 3 | IPR008077 | |
| Domain | ABC_transporter-like | 5.89e-06 | 50 | 262 | 7 | IPR003439 | |
| Domain | ABC_transporter_CS | 2.47e-05 | 42 | 262 | 6 | IPR017871 | |
| Domain | TSP_1 | 2.79e-05 | 63 | 262 | 7 | PF00090 | |
| Domain | MT | 3.39e-05 | 14 | 262 | 4 | PF12777 | |
| Domain | Dynein_HC_stalk | 3.39e-05 | 14 | 262 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 3.39e-05 | 14 | 262 | 4 | IPR013602 | |
| Domain | DHC_N2 | 3.39e-05 | 14 | 262 | 4 | PF08393 | |
| Domain | TSP1_rpt | 3.43e-05 | 65 | 262 | 7 | IPR000884 | |
| Domain | TSP1 | 3.43e-05 | 65 | 262 | 7 | PS50092 | |
| Domain | TSP1 | 3.43e-05 | 65 | 262 | 7 | SM00209 | |
| Domain | DHC_fam | 4.57e-05 | 15 | 262 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 4.57e-05 | 15 | 262 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 4.57e-05 | 15 | 262 | 4 | IPR004273 | |
| Domain | Ryanodine_recept-rel | 5.29e-05 | 6 | 262 | 3 | IPR015925 | |
| Domain | - | 5.29e-05 | 6 | 262 | 3 | 1.25.10.30 | |
| Domain | RIH_assoc-dom | 5.29e-05 | 6 | 262 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 5.29e-05 | 6 | 262 | 3 | PF08709 | |
| Domain | RIH_assoc | 5.29e-05 | 6 | 262 | 3 | PF08454 | |
| Domain | RIH_dom | 5.29e-05 | 6 | 262 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 5.29e-05 | 6 | 262 | 3 | IPR014821 | |
| Domain | RYDR_ITPR | 5.29e-05 | 6 | 262 | 3 | PF01365 | |
| Domain | ABC_TRANSPORTER_2 | 5.39e-05 | 48 | 262 | 6 | PS50893 | |
| Domain | ABC_tran | 5.39e-05 | 48 | 262 | 6 | PF00005 | |
| Domain | ABC_TRANSPORTER_1 | 6.07e-05 | 49 | 262 | 6 | PS00211 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 6.82e-05 | 50 | 262 | 6 | PS00650 | |
| Domain | 7tm_2 | 6.82e-05 | 50 | 262 | 6 | PF00002 | |
| Domain | AlbA_2 | 9.16e-05 | 7 | 262 | 3 | PF04326 | |
| Domain | Schlafen | 9.16e-05 | 7 | 262 | 3 | IPR029684 | |
| Domain | Schlafen_AAA_dom | 9.16e-05 | 7 | 262 | 3 | IPR007421 | |
| Domain | ARM-type_fold | ATR RYR3 ITPR1 URB1 PI4KA AP1G2 DOCK8 UBR4 ARFGEF2 ARFGEF1 NBEA CWC22 EIF4G2 DAAM2 STAG3 | 9.45e-05 | 339 | 262 | 15 | IPR016024 |
| Domain | DHC_N1 | 1.45e-04 | 8 | 262 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.45e-04 | 8 | 262 | 3 | IPR013594 | |
| Domain | GPCR_2_secretin-like | 1.91e-04 | 60 | 262 | 6 | IPR000832 | |
| Domain | GPCR_2-like | 1.91e-04 | 60 | 262 | 6 | IPR017981 | |
| Domain | C2_Calpain | 1.96e-04 | 2 | 262 | 2 | IPR033884 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 2.09e-04 | 61 | 262 | 6 | PS50261 | |
| Domain | GPCR_2_extracellular_dom | 2.30e-04 | 40 | 262 | 5 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 2.30e-04 | 40 | 262 | 5 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 2.30e-04 | 40 | 262 | 5 | PS50227 | |
| Domain | MIR | 3.04e-04 | 10 | 262 | 3 | PF02815 | |
| Domain | MIR_motif | 3.04e-04 | 10 | 262 | 3 | IPR016093 | |
| Domain | MIR | 3.04e-04 | 10 | 262 | 3 | PS50919 | |
| Domain | MIR | 3.04e-04 | 10 | 262 | 3 | SM00472 | |
| Domain | GAIN_dom_N | 4.14e-04 | 11 | 262 | 3 | IPR032471 | |
| Domain | GAIN | 4.14e-04 | 11 | 262 | 3 | PF16489 | |
| Domain | C2_III | 5.47e-04 | 12 | 262 | 3 | IPR033883 | |
| Domain | Calpain_III | 5.47e-04 | 12 | 262 | 3 | IPR022683 | |
| Domain | calpain_III | 5.47e-04 | 12 | 262 | 3 | SM00720 | |
| Domain | DUF2075 | 5.83e-04 | 3 | 262 | 2 | PF09848 | |
| Domain | DALR_anticod-bd | 5.83e-04 | 3 | 262 | 2 | IPR008909 | |
| Domain | DALR_1 | 5.83e-04 | 3 | 262 | 2 | SM00836 | |
| Domain | RyR | 5.83e-04 | 3 | 262 | 2 | PF02026 | |
| Domain | DUF2075 | 5.83e-04 | 3 | 262 | 2 | IPR018647 | |
| Domain | RR_TM4-6 | 5.83e-04 | 3 | 262 | 2 | PF06459 | |
| Domain | Ryan_recept | 5.83e-04 | 3 | 262 | 2 | IPR013333 | |
| Domain | BRINP | 5.83e-04 | 3 | 262 | 2 | IPR033237 | |
| Domain | Ryanodine_rcpt | 5.83e-04 | 3 | 262 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 5.83e-04 | 3 | 262 | 2 | IPR009460 | |
| Domain | DALR_1 | 5.83e-04 | 3 | 262 | 2 | PF05746 | |
| Domain | Pept_cys_AS | 5.94e-04 | 28 | 262 | 4 | IPR000169 | |
| Domain | ABC_TM1F | 5.94e-04 | 28 | 262 | 4 | PS50929 | |
| Domain | ABC1_TM_dom | 5.94e-04 | 28 | 262 | 4 | IPR011527 | |
| Domain | Calpain_III | 7.03e-04 | 13 | 262 | 3 | PF01067 | |
| Domain | bZIP_Maf | 7.03e-04 | 13 | 262 | 3 | IPR004826 | |
| Domain | Calpain_domain_III | 7.03e-04 | 13 | 262 | 3 | IPR022682 | |
| Domain | bZIP_Maf | 7.03e-04 | 13 | 262 | 3 | PF03131 | |
| Domain | SEMA | 8.84e-04 | 31 | 262 | 4 | PS51004 | |
| Domain | Semap_dom | 8.84e-04 | 31 | 262 | 4 | IPR001627 | |
| Domain | TIG | 8.84e-04 | 31 | 262 | 4 | PF01833 | |
| Domain | Sema | 8.84e-04 | 31 | 262 | 4 | SM00630 | |
| Domain | Sema | 8.84e-04 | 31 | 262 | 4 | PF01403 | |
| Domain | ATPase_dyneun-rel_AAA | 8.86e-04 | 14 | 262 | 3 | IPR011704 | |
| Domain | Calpain_cysteine_protease | 8.86e-04 | 14 | 262 | 3 | IPR022684 | |
| Domain | AAA_8 | 8.86e-04 | 14 | 262 | 3 | PF12780 | |
| Domain | AAA_5 | 8.86e-04 | 14 | 262 | 3 | PF07728 | |
| Domain | Dynein_heavy_chain_D4_dom | 8.86e-04 | 14 | 262 | 3 | IPR024317 | |
| Domain | IPT | 9.99e-04 | 32 | 262 | 4 | IPR002909 | |
| Domain | Plexin_repeat | 9.99e-04 | 32 | 262 | 4 | IPR002165 | |
| Domain | PSI | 9.99e-04 | 32 | 262 | 4 | PF01437 | |
| Domain | ConA-like_dom | LAMA1 RYR2 RYR3 FAT4 NBEA ADGRG6 RFPL4AL1 COL18A1 RFPL4A ADGRD2 | 1.09e-03 | 219 | 262 | 10 | IPR013320 |
| Domain | Peptidase_C2 | 1.10e-03 | 15 | 262 | 3 | PF00648 | |
| Domain | Peptidase_C2_calpain_cat | 1.10e-03 | 15 | 262 | 3 | IPR001300 | |
| Domain | CysPc | 1.10e-03 | 15 | 262 | 3 | SM00230 | |
| Domain | CALPAIN_CAT | 1.10e-03 | 15 | 262 | 3 | PS50203 | |
| Domain | DCB_dom | 1.15e-03 | 4 | 262 | 2 | IPR032629 | |
| Domain | Sec7_N | 1.15e-03 | 4 | 262 | 2 | PF12783 | |
| Domain | DCB | 1.15e-03 | 4 | 262 | 2 | PF16213 | |
| Domain | Sec7_C | 1.15e-03 | 4 | 262 | 2 | IPR015403 | |
| Domain | DUF1981 | 1.15e-03 | 4 | 262 | 2 | PF09324 | |
| Domain | Sec7_N | 1.15e-03 | 4 | 262 | 2 | IPR032691 | |
| Domain | REJ | 1.15e-03 | 4 | 262 | 2 | PS51111 | |
| Pubmed | EPRS1 DLGAP1 NCKAP1 MYCBP2 ADGRB1 ADGRB2 ADGRB3 PSMD11 TENM2 SRPRB RYR2 ITPR1 CACNG2 MET LONP1 ATAD3C PI4KA AFG3L2 TACC1 SIPA1L2 NOS1 HSPA2 RARS1 DTNA UBR4 NBEA SHOC2 AP3M1 CADPS EIF4G2 SLITRK5 MRPL3 SNRNP70 DIRAS2 | 3.02e-11 | 1139 | 273 | 34 | 36417873 | |
| Pubmed | GAPVD1 SETX SRPRB RYR2 MET PTPN3 VPS52 UBR5 PI4KA ADAMTS16 RBM14 TACC1 DYNC1H1 PLEKHA8 FAT4 EFCAB6 ARFGEF2 ARFGEF1 ABCC5 RNF213 NBEA AK8 PPP2R3A SLFN13 SLITRK5 TOR1AIP1 | 6.98e-10 | 777 | 273 | 26 | 35844135 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCC3 UBE4B MYCBP2 ADGRB2 PSMB10 SLCO4A1 TTC3 PLXNB2 JAK3 URB1 PROM2 PI4KA MCM3AP SLC35A2 PKD1 AP1G2 ABCD1 SIPA1L2 ABTB2 DYNC1H1 UBR4 ARFGEF2 SPATA20 TESK1 EML3 GRAMD2A C2CD3 HELZ2 ELL | 1.66e-08 | 1105 | 273 | 29 | 35748872 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | EPRS1 GAPVD1 SETX LAMA1 ADGRB1 TMCO4 FREM2 URB1 PI4KA MCM3AP PKD1 AHR UTRN NXF1 DYNC1H1 FAT4 APPBP2 RARS1 UBR4 RNF213 NBEA RANBP3L SERPINA9 | 2.47e-08 | 736 | 273 | 23 | 29676528 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ABCC3 B4GALNT1 ATR MYCBP2 LAMA1 ITGA1 PLXNB2 SRPRB ITPR1 MET SIAE COPS8 SLC35A2 BACE2 HSPA2 PLXNB1 WDR62 COL3A1 FAT4 ANPEP P3H3 ARFGEF2 ARFGEF1 RNF213 COL18A1 SLITRK5 ADGRE5 ATP2B1 TOR1AIP1 | 9.85e-08 | 1201 | 273 | 29 | 35696571 |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 1.42e-07 | 104 | 273 | 9 | 31240132 | |
| Pubmed | NCKAP1 UBE4B CAMTA2 TENM2 UNC5A UBR5 MCM3AP SIPA1L2 DYNC1H1 FNIP2 APPBP2 LGI2 CADPS BRINP2 DAAM2 ASB1 | 1.75e-07 | 407 | 273 | 16 | 12693553 | |
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 2.05e-07 | 33 | 273 | 6 | 25713288 | |
| Pubmed | PDE7A ACADSB MYCBP2 UNC5B TTC3 PLXNB2 SRPRB ITPR1 MET URB1 UBR5 PI4KA AFG3L2 TACC1 SIPA1L2 HSPA2 CLUH WDR62 DYNC2H1 DTNA DNAJC30 AHCTF1 UBR4 MRPL58 TRAPPC8 COL18A1 SF3B3 PANK4 EIF4G2 MRPL3 ATP2B1 TOR1AIP1 | 2.76e-07 | 1487 | 273 | 32 | 33957083 | |
| Pubmed | EPRS1 DLGAP1 CHAF1B PDE7A UBE4B MYCBP2 ADGRB3 HLCS TTC3 TUBGCP5 TRAPPC1 RYR3 PKD1 BACE2 HSPA2 UTRN DYNC1H1 UBR4 NR4A2 ARFGEF2 ABCC5 CRTAC1 NBEA ADAMTS8 DALRD3 CADPS EIF4G2 DAAM2 SNRNP70 | 3.99e-07 | 1285 | 273 | 29 | 35914814 | |
| Pubmed | 4.78e-07 | 3 | 273 | 3 | 9533023 | ||
| Pubmed | 4.78e-07 | 3 | 273 | 3 | 15225653 | ||
| Pubmed | Identification of 18 mouse ABC genes and characterization of the ABC superfamily in Mus musculus. | 8.61e-07 | 23 | 273 | 5 | 10708515 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | EPRS1 GAPVD1 NCKAP1 UBE4B PSMD11 PLXNB2 SRPRB URB1 VPS52 UBR5 PI4KA ALG5 ABCD1 HSPA2 DYNC1H1 RARS1 DYNC2H1 AHCTF1 UBR4 ARFGEF1 AP3M1 EIF4G2 TOR1AIP1 | 1.85e-06 | 942 | 273 | 23 | 31073040 |
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 1.90e-06 | 4 | 273 | 3 | 23413940 | |
| Pubmed | 1.90e-06 | 4 | 273 | 3 | 9607712 | ||
| Pubmed | Small Maf proteins interact with the human transcription factor TCF11/Nrf1/LCR-F1. | 1.90e-06 | 4 | 273 | 3 | 8932385 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | CEACAM5 NCKAP1 KIF12 PBLD ITGA1 SIAE FCGBP COPS8 PROM2 PKD1 SERPING1 CAPN5 HSPA2 UTRN DYNC1H1 DNHD1 RARS1 ANPEP DYNC2H1 AHCTF1 COL18A1 CAPN7 ABCB11 CCDC180 | 1.94e-06 | 1016 | 273 | 24 | 19056867 |
| Pubmed | ACADSB SRPRB LONP1 COQ8A AFG3L2 UBR4 AP3M1 ORC5 PANK4 EIF4G2 SLFN11 ATP2B1 TOR1AIP1 | 1.95e-06 | 323 | 273 | 13 | 24797263 | |
| Pubmed | The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. | 2.92e-06 | 29 | 273 | 5 | 15203201 | |
| Pubmed | DLGAP1 ADGRB1 ADGRB2 ADGRB3 TENM2 CACNG2 AFG3L2 NOS1 SLITRK5 CACNG4 | 4.00e-06 | 197 | 273 | 10 | 36604605 | |
| Pubmed | 4.73e-06 | 5 | 273 | 3 | 9150357 | ||
| Pubmed | Interplay between scatter factor receptors and B plexins controls invasive growth. | 4.73e-06 | 5 | 273 | 3 | 15184888 | |
| Pubmed | 6.19e-06 | 163 | 273 | 9 | 12466854 | ||
| Pubmed | 6.19e-06 | 163 | 273 | 9 | 16512683 | ||
| Pubmed | ACADSB MYCBP2 PSMD11 TUBGCP5 TOMM5 SRPRB VPS52 COQ8A PI4KA AFG3L2 AHR SIPA1L2 WDR62 DYNC2H1 DNAJC30 ORC5 PANK4 | 7.24e-06 | 606 | 273 | 17 | 36538041 | |
| Pubmed | 9.40e-06 | 6 | 273 | 3 | 10559499 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 9.40e-06 | 6 | 273 | 3 | 25966694 | |
| Pubmed | 9.40e-06 | 6 | 273 | 3 | 20519450 | ||
| Pubmed | An anchored molecular map of mouse chromosome 6 with an analysis of interference. | 9.40e-06 | 6 | 273 | 3 | 8563173 | |
| Pubmed | 9.40e-06 | 6 | 273 | 3 | 11025215 | ||
| Pubmed | 9.40e-06 | 6 | 273 | 3 | 23463619 | ||
| Pubmed | Improving GENCODE reference gene annotation using a high-stringency proteogenomics workflow. | 9.40e-06 | 6 | 273 | 3 | 27250503 | |
| Pubmed | Schlafen, a new family of growth regulatory genes that affect thymocyte development. | 9.40e-06 | 6 | 273 | 3 | 9846487 | |
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 9.40e-06 | 6 | 273 | 3 | 16844763 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | ABCC3 UNC5B SLCO4A1 MET PTPN3 PROM2 PI4KA SLC35A2 PLXNB1 COL3A1 DTNA ARFGEF2 ARFGEF1 ABCC5 GRAMD2B ATP2B1 | 1.31e-05 | 569 | 273 | 16 | 30639242 |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | HLCS IER5 PSMD11 PLXNB2 MET PTPN3 LONP1 VPS52 UBR5 UTRN DYNC1H1 UBR4 TNS2 PPP2R3A SF3B3 ATP2B1 | 1.43e-05 | 573 | 273 | 16 | 28330616 |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | DLGAP1 NCKAP1 UBE4B ADGRB2 AGAP11 CACNG2 ATAD3C UBR5 PI4KA DYNC1H1 NBEA | 1.56e-05 | 281 | 273 | 11 | 28706196 |
| Pubmed | 1.64e-05 | 7 | 273 | 3 | 11860456 | ||
| Pubmed | DENND4A UNC5B TRAPPC1 VPS52 PPP1R21 AHCTF1 NBEA TESK1 AP3M1 SLITRK5 TOR1AIP1 | 1.78e-05 | 285 | 273 | 11 | 34369648 | |
| Pubmed | An approach based on a genome-wide association study reveals candidate loci for narcolepsy. | 2.39e-05 | 193 | 273 | 9 | 20677014 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EPRS1 GAPVD1 DENND4A ATR NCKAP1 PSMD11 TTC3 SRPRB LONP1 URB1 PI4KA RBM14 CLUH NXF1 DYNC1H1 DNHD1 RARS1 DYNC2H1 UBR4 CWC22 TESK1 SF3B3 MAPK15 EIF4G2 SNRNP70 ATP2B1 TOR1AIP1 | 2.45e-05 | 1425 | 273 | 27 | 30948266 |
| Pubmed | 2.60e-05 | 8 | 273 | 3 | 19619625 | ||
| Pubmed | 2.81e-05 | 197 | 273 | 9 | 31620119 | ||
| Pubmed | 2.83e-05 | 75 | 273 | 6 | 20637190 | ||
| Pubmed | NCKAP1 ADGRB1 PBLD COQ8A PI4KA AFG3L2 PPP1R21 UBR4 RNF213 TNS2 TRAPPC8 | 3.22e-05 | 304 | 273 | 11 | 32235678 | |
| Pubmed | PRTG PDE7A MYCBP2 NAB1 CCDC90B SEMA3G TTC3 PLXNB2 ITPR1 FREM2 PKD1 SIPA1L2 HSPA2 UTRN MNT ABCC5 RPUSD1 EML3 DALRD3 COL18A1 GRAMD2B SNRNP70 TOR1AIP1 DIRAS2 | 3.69e-05 | 1215 | 273 | 24 | 15146197 | |
| Pubmed | A gene expression map of human chromosome 21 orthologues in the mouse. | 3.79e-05 | 158 | 273 | 8 | 12466855 | |
| Pubmed | The G protein-coupled receptor repertoires of human and mouse. | 3.81e-05 | 79 | 273 | 6 | 12679517 | |
| Pubmed | 3.88e-05 | 9 | 273 | 3 | 19531582 | ||
| Pubmed | NCKAP1 ACADSB LONP1 VPS52 COQ8A ALG5 AFG3L2 CLUH DYNC1H1 CWC22 ORC5 PANK4 EIF4G2 SLFN11 TOR1AIP1 | 4.25e-05 | 560 | 273 | 15 | 35241646 | |
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 4.27e-05 | 118 | 273 | 7 | 19156168 | |
| Pubmed | EPRS1 GAPVD1 SETX CAMTA2 TTC3 ITPR1 SIAE URB1 COQ8A NFE2L1 PI4KA UTRN PLXNB1 AHCTF1 NFKBIZ AP3M1 GRAMD2A COL18A1 GRAMD2B EIF4G2 ADGRE5 ATP2B1 | 5.29e-05 | 1084 | 273 | 22 | 11544199 | |
| Pubmed | 5.51e-05 | 10 | 273 | 3 | 12730235 | ||
| Pubmed | 5.52e-05 | 52 | 273 | 5 | 26633812 | ||
| Pubmed | Calsyntenins function as synaptogenic adhesion molecules in concert with neurexins. | 5.52e-05 | 52 | 273 | 5 | 24613359 | |
| Pubmed | DNA polymerase θ protects leukemia cells from metabolically induced DNA damage. | 6.14e-05 | 2 | 273 | 2 | 36580665 | |
| Pubmed | 6.14e-05 | 2 | 273 | 2 | 17880893 | ||
| Pubmed | TARP subtypes differentially and dose-dependently control synaptic AMPA receptor gating. | 6.14e-05 | 2 | 273 | 2 | 17880894 | |
| Pubmed | 6.14e-05 | 2 | 273 | 2 | 3035575 | ||
| Pubmed | 6.14e-05 | 2 | 273 | 2 | 1534146 | ||
| Pubmed | Functional regulation of semaphorin receptors by proprotein convertases. | 6.14e-05 | 2 | 273 | 2 | 12533544 | |
| Pubmed | A synthetic planar cell polarity system reveals localized feedback on Fat4-Ds1 complexes. | 6.14e-05 | 2 | 273 | 2 | 28826487 | |
| Pubmed | 6.14e-05 | 2 | 273 | 2 | 24594598 | ||
| Pubmed | Disruption of T lymphocyte positive and negative selection in mice lacking the CD8 beta chain. | 6.14e-05 | 2 | 273 | 2 | 7889415 | |
| Pubmed | 6.14e-05 | 2 | 273 | 2 | 21080915 | ||
| Pubmed | 6.14e-05 | 2 | 273 | 2 | 3025647 | ||
| Pubmed | 6.14e-05 | 2 | 273 | 2 | 9233619 | ||
| Pubmed | 6.14e-05 | 2 | 273 | 2 | 8898078 | ||
| Pubmed | Genetic analysis of the cytoplasmic dynein subunit families. | 6.14e-05 | 2 | 273 | 2 | 16440056 | |
| Pubmed | Perinatal synthetic lethality and hematopoietic defects in compound mafG::mafK mutant mice. | 6.14e-05 | 2 | 273 | 2 | 10716933 | |
| Pubmed | 6.14e-05 | 2 | 273 | 2 | 11342101 | ||
| Pubmed | 6.14e-05 | 2 | 273 | 2 | 14550562 | ||
| Pubmed | 6.14e-05 | 2 | 273 | 2 | 10716990 | ||
| Pubmed | An atypical form of AOA2 with myoclonus associated with mutations in SETX and AFG3L2. | 6.14e-05 | 2 | 273 | 2 | 25927548 | |
| Pubmed | 6.14e-05 | 2 | 273 | 2 | 23012363 | ||
| Pubmed | 6.14e-05 | 2 | 273 | 2 | 37742185 | ||
| Pubmed | NLRC4 and TLR5 each contribute to host defense in respiratory melioidosis. | 6.14e-05 | 2 | 273 | 2 | 25232720 | |
| Pubmed | Transcriptional diversity at the duplicated human CD8 beta loci. | 6.14e-05 | 2 | 273 | 2 | 8436166 | |
| Pubmed | 6.14e-05 | 2 | 273 | 2 | 12598906 | ||
| Pubmed | 6.14e-05 | 2 | 273 | 2 | 3169881 | ||
| Pubmed | Esr, a second locus in the house mouse controlling esterase-5. | 6.14e-05 | 2 | 273 | 2 | 7103930 | |
| Pubmed | Genetic functions of the NAIP family of inflammasome receptors for bacterial ligands in mice. | 6.14e-05 | 2 | 273 | 2 | 27114610 | |
| Pubmed | 6.14e-05 | 2 | 273 | 2 | 23940371 | ||
| Pubmed | 6.14e-05 | 2 | 273 | 2 | 18417613 | ||
| Pubmed | 6.14e-05 | 2 | 273 | 2 | 27546231 | ||
| Pubmed | Ly-C: a third locus specifying alloantigens expressed only on thymocytes and lymphocytes. | 6.14e-05 | 2 | 273 | 2 | 5558567 | |
| Pubmed | 6.14e-05 | 2 | 273 | 2 | 19940359 | ||
| Pubmed | 6.14e-05 | 2 | 273 | 2 | 25402425 | ||
| Pubmed | 6.14e-05 | 2 | 273 | 2 | 12034498 | ||
| Pubmed | Acidic glycosaminoglycans and laminin-1 in renal corpuscles of mutant blebs (my) and control mice. | 6.14e-05 | 2 | 273 | 2 | 9302549 | |
| Pubmed | 6.14e-05 | 2 | 273 | 2 | 10340910 | ||
| Pubmed | 6.14e-05 | 2 | 273 | 2 | 37586642 | ||
| Pubmed | The Features of GGT in Patients with ATP8B1 or ABCB11 Deficiency Improve the Diagnostic Efficiency. | 6.14e-05 | 2 | 273 | 2 | 27050426 | |
| Pubmed | Phospholipase D2 mediates signaling by ATPase class I type 8B membrane 1. | 6.14e-05 | 2 | 273 | 2 | 23213138 | |
| Pubmed | Cutting edge: Mouse NAIP1 detects the type III secretion system needle protein. | 6.14e-05 | 2 | 273 | 2 | 24043898 | |
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 6.14e-05 | 2 | 273 | 2 | 21531043 | |
| Pubmed | 6.14e-05 | 2 | 273 | 2 | 12034776 | ||
| Pubmed | 6.14e-05 | 2 | 273 | 2 | 16678258 | ||
| Pubmed | Association of the EGF-TM7 receptor CD97 expression with FLT3-ITD in acute myeloid leukemia. | 6.14e-05 | 2 | 273 | 2 | 26462154 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily B | 1.20e-06 | 3 | 193 | 3 | 912 | |
| GeneFamily | Schlafen family | 4.06e-05 | 7 | 193 | 3 | 1110 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 3.38e-04 | 3 | 193 | 2 | 287 | |
| GeneFamily | C2 domain containing|Calpains | 4.96e-04 | 15 | 193 | 3 | 975 | |
| Coexpression | GSE2585_CTEC_VS_THYMIC_DC_UP | NHSL2 NAB1 CPED1 ADCY8 TACC1 CLUH ARFGEF2 TRAPPC8 COL18A1 CADPS GRAMD2B DIRAS2 | 1.14e-06 | 200 | 268 | 12 | M6271 |
| Coexpression | SMID_BREAST_CANCER_BASAL_DN | ABCC3 ABCA3 CEACAM5 MAOA ACADSB NAIP ADGRB2 PBLD SEMA3G ITPR1 HSPA2 PLXNB1 APPBP2 NR4A2 NBEA ABCG1 BRINP2 CATSPERB CACNG4 UGT2B11 MUC6 | 1.19e-05 | 699 | 268 | 21 | M4960 |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | GABRP ABCC3 CEACAM5 SLCO4A1 FCGBP PROM2 CAPN5 SIPA1L2 BACE2 PDE11A FUT9 | 1.83e-08 | 183 | 272 | 11 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | LAMA1 PKD1L2 RYR2 RYR3 FREM2 SCN9A ADAMTS16 OTOA MGAM FAT4 EFCAB6 | 1.94e-08 | 184 | 272 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | LAMA1 PKD1L2 RYR2 RYR3 FREM2 SCN9A ADAMTS16 OTOA MGAM FAT4 EFCAB6 | 1.94e-08 | 184 | 272 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | LAMA1 PKD1L2 RYR2 RYR3 FREM2 SCN9A ADAMTS16 OTOA MGAM FAT4 EFCAB6 | 1.94e-08 | 184 | 272 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | DLGAP1 PRTG ITGA1 CPED1 ADCY8 SCN9A NOS1 FLT3 CRTAC1 PTCHD4 LGI2 | 4.56e-08 | 200 | 272 | 11 | 107854f4855fc99c9f7e737eb246f0d868e6c5fd |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | ITGA1 ADCY8 CENPVL2 SCN9A KCNK2 OR1K1 UTRN WDR72 FLT3 PTCHD4 | 1.39e-07 | 176 | 272 | 10 | d09e28606e2a6ed1f660898316765ca215085c18 |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-07 | 185 | 272 | 10 | f4ac62009c0ad3346e71b809e17727303c4df153 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.97e-07 | 191 | 272 | 10 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | Epithelial_cells-Club_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | GABRP ABCC3 CEACAM5 FCGBP PROM2 SIPA1L2 ANPEP ABCC5 P2RY6 GRAMD2B | 3.59e-07 | 195 | 272 | 10 | b758676abfc4e6930b696d270ecc0ea461b87a54 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYCBP2 KIF12 TTC3 BACE2 DYNC1H1 DYNC2H1 ARFGEF1 NBEA CADPS ATP2B1 | 3.59e-07 | 195 | 272 | 10 | 7796ea9247f4c63762f0de8490fed08b9717fa23 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MYCBP2 KIF12 TTC3 BACE2 DYNC1H1 DYNC2H1 ARFGEF1 NBEA CADPS ATP2B1 | 3.59e-07 | 195 | 272 | 10 | 3e519cffa6144a62b06124642a14c9ff39b76554 |
| ToppCell | NS-moderate-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | GABRP CEACAM5 NCKAP1 ATP8B1 PLXNB2 MET PTPN3 PROM2 CAPN5 BACE2 | 3.77e-07 | 196 | 272 | 10 | 70384c1da9baed843f414cfd1403ddd586a2db07 |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.13e-07 | 198 | 272 | 10 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2|Neuronal / cells hierarchy compared to all cells using T-Statistic | RYR3 KCNK2 UTRN FAT4 NR4A2 ADGRG6 CDH24 GRAMD2B DIRAS2 HCRTR2 | 4.53e-07 | 200 | 272 | 10 | d31e26387d879ee30731c497cea6aaf4746e40d9 |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.20e-07 | 167 | 272 | 9 | a6ff7a3d9b80839c0efa91658836812e868561fa | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_SLITRK6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.02e-06 | 169 | 272 | 9 | 1c9e54e7b14eb99996590fb93b257cf881a9f184 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 1.02e-06 | 169 | 272 | 9 | 241644823e6f949aaf4c671d4579721d7ef6b0e5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBC1D26|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.02e-06 | 169 | 272 | 9 | 2abdd8ae9a5d88aac30992142d1b502c959bc015 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-06 | 173 | 272 | 9 | 11e95a60b5f6f07f27154a23203bac431e7528c6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.88e-06 | 182 | 272 | 9 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-5_PVALB_TRIM67|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.06e-06 | 184 | 272 | 9 | 7f6c8912677764d438ab0555faca344d74c2f483 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-06 | 185 | 272 | 9 | ae53aa2ecfe418a5dbd7d963a995bc06dab94f56 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.25e-06 | 186 | 272 | 9 | 56c139e679d640ea901ead657a8e8887e0fca098 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 2.25e-06 | 186 | 272 | 9 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-06 | 189 | 272 | 9 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.79e-06 | 191 | 272 | 9 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.79e-06 | 191 | 272 | 9 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | LPS-antiTNF-Myeloid-Myeloid_granulocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.83e-06 | 143 | 272 | 8 | 4a0f26eef935fe68a1da5d319503059a8a8682dd | |
| ToppCell | LPS-antiTNF-Myeloid-Myeloid_granulocytic-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.83e-06 | 143 | 272 | 8 | 65328a0a2f3972fac596e07933e74b2ef7cceb84 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-06 | 192 | 272 | 9 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | Hippocampus-Endothelial|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.91e-06 | 192 | 272 | 9 | 36deadab892d3e639a71f33697bb2d3cbbaa5372 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.04e-06 | 193 | 272 | 9 | 4979862c0c16e6b4baa4c79894f1d237c861f5a5 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ITGA1 SERPING1 TACC1 HSPA2 TNS2 ADAMTS8 ADGRG6 COL18A1 DAAM2 | 3.04e-06 | 193 | 272 | 9 | b2abe939027a69b60d83a28d4d4cc53ba1dee4c5 |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ITGA1 SERPING1 TACC1 HSPA2 TNS2 ADAMTS8 ADGRG6 COL18A1 DAAM2 | 3.04e-06 | 193 | 272 | 9 | d75f334fe3d9f39ef02a5de0f8202f7a761a8fc8 |
| ToppCell | wk_20-22-Hematologic-Myeloid-DC1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | SLC66A1 CENPVL2 CENPVL1 FNIP2 FLT3 ANPEP RFPL4AL1 RFPL4A P2RY6 | 3.04e-06 | 193 | 272 | 9 | a260d943e9db966e4ce7d642313fd11354c2d2ba |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ITGA1 SERPING1 TACC1 HSPA2 TNS2 ADAMTS8 ADGRG6 COL18A1 DAAM2 | 3.04e-06 | 193 | 272 | 9 | 41ea268e7697101fe70d8ef1045f3a43b9311739 |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.04e-06 | 193 | 272 | 9 | 5581a5ebcd21a2a8062ccfb917f088ec67a10a9c | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ITGA1 SERPING1 TACC1 HSPA2 TNS2 ADAMTS8 ADGRG6 COL18A1 DAAM2 | 3.04e-06 | 193 | 272 | 9 | 87ce81ff5b27d9c4300826d76ff5a62e9c408d5d |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 3.04e-06 | 193 | 272 | 9 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-06 | 194 | 272 | 9 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.17e-06 | 194 | 272 | 9 | 1bcb3fafd498614f7bac2b1c9b7de56e39110f65 | |
| ToppCell | IPF-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 3.17e-06 | 194 | 272 | 9 | e8a9005963704286bcc50785bda8d7d63ec001b1 | |
| ToppCell | 3'-Distal_airway-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ITGA1 SERPING1 TACC1 HSPA2 TNS2 ADAMTS8 ADGRG6 COL18A1 DAAM2 | 3.17e-06 | 194 | 272 | 9 | f5e3e675187afb6efa774f2a8d685efcf813de82 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.60e-06 | 197 | 272 | 9 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.60e-06 | 197 | 272 | 9 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.65e-06 | 148 | 272 | 8 | afebb64365c94b9476494bffe7c364677f19c8cf | |
| ToppCell | Thalamus-Neuronal-Inhibitory|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.65e-06 | 148 | 272 | 8 | 5f82e5ecacfd223020b8ee975c17d68c1fe6db38 | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.75e-06 | 198 | 272 | 9 | d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.75e-06 | 198 | 272 | 9 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.07e-06 | 200 | 272 | 9 | a9cdddc4e985dae59521e557479c24fcc2ac727d | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.07e-06 | 200 | 272 | 9 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.07e-06 | 200 | 272 | 9 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.07e-06 | 200 | 272 | 9 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.07e-06 | 200 | 272 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2-SLC17A7_IL15--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.07e-06 | 200 | 272 | 9 | 9103e6f72a04f66f2b7069b0d71a719e9b10026b | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.07e-06 | 200 | 272 | 9 | 9719fabddc34051949468a7520289e3c750de4f8 | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2-SLC17A7_IL15|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.07e-06 | 200 | 272 | 9 | e5e97767beb4413e87c9817a60a5f1ee5209198a | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.07e-06 | 200 | 272 | 9 | 33b9199e0dfc267e2cea20b82d1c167f8adcc635 | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2-SLC17A7_IL15-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.07e-06 | 200 | 272 | 9 | 48fd48990a6833066be314dc5b66b90893f7ea8f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.07e-06 | 200 | 272 | 9 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.07e-06 | 200 | 272 | 9 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| ToppCell | Neuronal-Inhibitory-iB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.07e-06 | 200 | 272 | 9 | 45ddc5ef2caa87ada88327b63ba9b150a6bb3aa5 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.90e-06 | 154 | 272 | 8 | 65dbb60f636562eeba3dafadae9c0c7db2b27476 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.21e-06 | 159 | 272 | 8 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Col15a1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.21e-06 | 159 | 272 | 8 | 34c90711c5857cf6ada7b3acff99f1d48c7caf29 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.80e-06 | 161 | 272 | 8 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.45e-06 | 163 | 272 | 8 | bba830a302919c8b33f914a8839877fc21dd28a0 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Chodl_(Low-threshold_spiking_interneuron,_Npy+/Sst+)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.65e-06 | 77 | 272 | 6 | 7bb18406d404c51ee938cc577c155dc51868ddb9 | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Chodl_(Low-threshold_spiking_interneuron,_Npy+/Sst+)|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.65e-06 | 77 | 272 | 6 | ac311740424ff75b478b3c19fa0fae93776eb54e | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Chodl_(Low-threshold_spiking_interneuron,_Npy+/Sst+)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.65e-06 | 77 | 272 | 6 | 9f2dbf922acb905d636427a766a217c0db9671d2 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.29e-06 | 168 | 272 | 8 | 6db453cbbbaf4144a86fadcfa5805d33396713b5 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.70e-06 | 169 | 272 | 8 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.70e-06 | 169 | 272 | 8 | 0c341f91dc21aaf92bead18d59684d11510502ce | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-05 | 170 | 272 | 8 | 84d49a1f2989d98bd0acf9ec2d59f1042fc0f55b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-05 | 172 | 272 | 8 | cecfe5cf20f317ea01b4604789e07a14481c4cd6 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-05 | 174 | 272 | 8 | a0ccda8fd6f55251cdeff24cf66e72e4a31d2104 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.20e-05 | 174 | 272 | 8 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-05 | 175 | 272 | 8 | 19eda8b5d39dc93d79737ebdbeeba5ec0cb23c51 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.30e-05 | 176 | 272 | 8 | 682a1dfcc507ec540f5fadf08e872533ea9f0291 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS-Secretory|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.36e-05 | 177 | 272 | 8 | 0f210cfb61b873c5fd77dc17eadf4d017306500e | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Secretory/RAS|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.36e-05 | 177 | 272 | 8 | 779ba86f53650772755b52460be03f18bb204e55 | |
| ToppCell | 3'_v3-lymph-node_spleen-Mast-Mast_cell_lympho|lymph-node_spleen / Manually curated celltypes from each tissue | 1.36e-05 | 177 | 272 | 8 | 53040dbeb18574a48e352e4bce252c7c3018762c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.47e-05 | 179 | 272 | 8 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.47e-05 | 179 | 272 | 8 | af0b54c9ea0b6e4210f22dbb6e88ecd3276a5f86 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.53e-05 | 180 | 272 | 8 | 9adebde5f4ca6dcb90e9113622862e14298465ac | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.60e-05 | 181 | 272 | 8 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.60e-05 | 181 | 272 | 8 | 13270b6ba6a9c8e5681c6f40000c643ce1d9344a | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 181 | 272 | 8 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_IL7R|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.60e-05 | 181 | 272 | 8 | 3e3c903b522dced6bec5dc447cc3f8bf9a9749e3 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-05 | 181 | 272 | 8 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.66e-05 | 182 | 272 | 8 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.66e-05 | 182 | 272 | 8 | e9fcae9d03a6faf85b91882c5da699037bc61aeb | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.66e-05 | 182 | 272 | 8 | 04ccfa951eaa31fed6d140edb6c702d49363c5fa | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.73e-05 | 183 | 272 | 8 | f8b636391f752e379a5c5575fd898bdf0907a3b8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_KLHL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.73e-05 | 183 | 272 | 8 | 439b1d1373b7cc73d65f3b59037a6def7cf8f4ba | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_ISOC1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.73e-05 | 183 | 272 | 8 | 7961e05c6e9964da159059c6bfb4f7e7e14308c2 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 1.80e-05 | 184 | 272 | 8 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | COPD-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 1.80e-05 | 184 | 272 | 8 | 42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.80e-05 | 184 | 272 | 8 | 25ccf08a8a26d7e7827b6357f33a53aaf423577d | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-05 | 185 | 272 | 8 | efcfbf5a48b3ea9a425183e5c2eec6a9585415a0 | |
| Drug | GTP[S] | GABRP SETX GPR182 HLCS ASIC3 ADCY8 RYR3 ITPR1 CACNG2 PTPN3 PI4KA PKD1 SCN9A PLD2 NMBR MGAM HTR1B GALR3 ARFGEF1 NBEA GRM6 CCKAR TG CACNG4 HCRTR2 HRH3 | 8.64e-09 | 591 | 267 | 26 | CID000001764 |
| Drug | riluzole | GABRP ASIC3 RYR2 RYR3 ITPR1 CACNG2 PKD1 SCN9A KCNK2 NOS1 NFKBIZ GRM6 CACNG4 | 1.51e-07 | 174 | 267 | 13 | CID000005070 |
| Drug | Clorocruoro Hem | RYR2 RYR3 ITPR1 COQ8A CAPN5 PLD2 CHRNA10 NOS1 CCKAR MAPK15 ATP2B1 | 2.27e-07 | 123 | 267 | 11 | CID003518809 |
| Drug | phenytoin | ASIC3 PLXNB2 RYR2 RYR3 ITPR1 CACNG2 SLC35A2 PKD1 SCN9A CAPN5 NOS1 LGI2 ADGRE5 CACNG4 | 3.42e-07 | 219 | 267 | 14 | CID000001775 |
| Drug | verapamil | ABCC3 ABCA3 ATP8B1 ASIC3 ADCY8 RYR2 RYR3 ITPR1 CACNG2 PKD1 SCN9A ABCD1 CHRNA10 NOS1 MGAM HCN3 ABCC5 ABCG1 ABCB11 CACNG4 ATP2B1 | 3.81e-07 | 490 | 267 | 21 | CID000002520 |
| Drug | AC1L1KC5 | GPR182 NAIP RYR2 RYR3 ITPR1 CACNG2 PTPN3 SIAE PI4KA PKD1 AHR PLD2 NMBR CHRNA10 NOS1 GRM6 CCKAR TG MAPK15 P2RY6 CACNG4 ATP2B1 | 4.85e-07 | 541 | 267 | 22 | CID000005428 |
| Drug | gabapentin | GABRP MAOA ASIC3 RYR2 RYR3 ITPR1 CACNG2 PKD1 SCN9A ANPEP GRM6 CACNG4 | 7.87e-07 | 169 | 267 | 12 | CID000003446 |
| Drug | lamotrigine | 1.14e-06 | 116 | 267 | 10 | CID000003878 | |
| Drug | NSC7524 | ASIC3 ADCY8 RYR2 RYR3 ITPR1 CACNG2 PKD1 SCN9A CHRNA10 MGAM HTR1B CACNG4 | 1.72e-06 | 182 | 267 | 12 | CID000005657 |
| Drug | CNS 1145 | 2.09e-06 | 33 | 267 | 6 | CID000190902 | |
| Drug | IHC-64 | 2.09e-06 | 33 | 267 | 6 | CID000162753 | |
| Drug | ethosuximide | 2.49e-06 | 74 | 267 | 8 | CID000003291 | |
| Drug | Hesperetin [520-33-2]; Down 200; 13.2uM; PC3; HT_HG-U133A | ABCC3 SETX UBE4B NAB1 MET SLC35A2 UTRN ARFGEF2 ARFGEF1 PTPN21 CCNE2 TOR1AIP1 | 2.56e-06 | 189 | 267 | 12 | 6750_DN |
| Drug | isradipine | 2.75e-06 | 100 | 267 | 9 | CID000003784 | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | B4GALNT1 GSDMB HLCS RYR2 MET URB1 MCM3AP SLC35A2 TACC1 DTNA TLR5 CACNG4 | 2.85e-06 | 191 | 267 | 12 | 5234_DN |
| Drug | PF-00875133-00 [351322-64-0]; Up 200; 10uM; MCF7; HT_HG-U133A | ABCC3 HLCS SLC30A3 SLC35A2 CHRNA10 WDR62 DTNA PPP2R3A TLR5 BRINP2 ALOXE3 TOR1AIP1 | 3.35e-06 | 194 | 267 | 12 | 5923_UP |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | MAOA NAB1 PLD2 PDE11A ICOSLG EFCAB6 P3H3 UBR4 NR4A2 TESK1 CACNG4 MUC6 | 3.53e-06 | 195 | 267 | 12 | 2699_UP |
| Drug | PCB 95 | 3.67e-06 | 10 | 267 | 4 | CID000038012 | |
| Drug | Isoconazole [27523-40-6]; Down 200; 9.6uM; HL60; HG-U133A | CEACAM5 UNC5B JAK3 RBM14 TACC1 ICOSLG APPBP2 SF3B3 P2RY6 CCNE2 ASB1 ZNF654 | 3.93e-06 | 197 | 267 | 12 | 1372_DN |
| Drug | lanthanum | 4.83e-06 | 136 | 267 | 10 | CID000023926 | |
| Drug | AC1L1DXE | EPRS1 ASIC3 RYR2 RYR3 ITPR1 CACNG2 PKD1 AHR NOS1 HTR1B RARS1 CCKAR CACNG4 HRH3 | 1.30e-05 | 299 | 267 | 14 | CID000002548 |
| Drug | gallopamil | 1.35e-05 | 67 | 267 | 7 | CID000001234 | |
| Drug | procaine | GABRP ASIC3 RYR2 RYR3 ITPR1 CACNG2 PKD1 SCN9A CHRNA10 CACNG4 | 1.37e-05 | 153 | 267 | 10 | CID000004914 |
| Drug | baclofen | GABRP ADCY8 RYR2 RYR3 ITPR1 CACNG2 PKD1 HTR1B GRM6 EIF4G2 CACNG4 | 1.69e-05 | 191 | 267 | 11 | CID000002284 |
| Drug | bepridil | 1.83e-05 | 126 | 267 | 9 | CID000002351 | |
| Drug | CNQX | 1.83e-05 | 126 | 267 | 9 | CID000002821 | |
| Drug | Lactobionic acid [96-82-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | CEACAM5 HLCS TUBGCP5 ITPR1 NOS1 UTRN ICOSLG DTNA ORC5 TOR1AIP1 ELL | 2.04e-05 | 195 | 267 | 11 | 3246_UP |
| Drug | Mevalonic-D, L acid lactone [674-26-0]; Up 200; 30.8uM; HL60; HT_HG-U133A | MAOA NCKAP1 ITGA1 CAPN5 COL3A1 UBR4 GRM6 CCKAR ALOXE3 HCRTR2 HRH3 | 2.25e-05 | 197 | 267 | 11 | 2718_UP |
| Drug | halothane | GABRP ADCY8 RYR2 RYR3 ITPR1 CACNG2 PKD1 KCNK2 AHR CHRNA10 NOS1 CYP4F22 CACNG4 ATP2B1 | 2.25e-05 | 314 | 267 | 14 | CID000003562 |
| Drug | carbachol | ADCY8 RYR2 RYR3 ITPR1 CACNG2 PTPN3 PI4KA PKD1 AHR PLD2 NMBR CHRNA10 NOS1 HTR1B GALR3 GRM6 CCKAR TG MAPK15 CACNG4 ATP2B1 HRH3 | 2.27e-05 | 688 | 267 | 22 | CID000002551 |
| Drug | Cimetidine [51481-61-9]; Up 200; 15.8uM; MCF7; HT_HG-U133A | HLCS PSMD11 ASIC3 SLC30A3 ITPR1 MCM3AP EML3 PPP2R3A CCNE2 ASB1 ELL | 2.36e-05 | 198 | 267 | 11 | 1464_UP |
| Drug | CAS 298-57-7 | 2.37e-05 | 73 | 267 | 7 | CID000002761 | |
| Drug | Ticarcillin sodium [4697-14-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A | DENND4A B4GALNT1 BRIP1 BRINP1 PSMD11 DTNA ADAMTS8 EML3 PPP2R3A CCNE2 ASB1 | 2.47e-05 | 199 | 267 | 11 | 7185_UP |
| Drug | Niacin [59-67-6]; Down 200; 32.4uM; PC3; HT_HG-U133A | DENND4A ABCA3 B4GALNT1 UNC5B COPS8 PLD2 WDR62 NR4A2 EML3 ORC5 ASB1 | 2.47e-05 | 199 | 267 | 11 | 6702_DN |
| Drug | Chlorthalidone [77-36-1]; Up 200; 11.8uM; PC3; HT_HG-U133A | ACADSB HLCS GPR135 ITGA1 URB1 MCM3AP SLC35A2 UTRN PLXNB1 PDE11A STAG3 | 2.58e-05 | 200 | 267 | 11 | 7152_UP |
| Drug | myo-inositol | TRIT1 GPR182 ADCY8 RYR2 RYR3 ITPR1 CACNG2 PTPN3 PI4KA PIP4K2A PKD1 PLD2 NMBR CHRNA10 HTR1B GALR3 GRM6 CCKAR MAPK15 P2RY6 ALOXE3 CACNG4 ATP2B1 HRH3 | 3.35e-05 | 811 | 267 | 24 | CID000000892 |
| Drug | lavendustin A | 3.58e-05 | 171 | 267 | 10 | CID000003894 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 3.98e-05 | 79 | 267 | 7 | CID005287890 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | GPR182 ADCY8 RYR2 RYR3 ITPR1 CACNG2 PTPN3 PI4KA PKD1 PLD2 NMBR GRM6 CCKAR MAPK15 P2RY6 EIF4G2 CACNG4 ATP2B1 HRH3 | 4.57e-05 | 568 | 267 | 19 | CID000000806 |
| Drug | papaverine | 4.57e-05 | 176 | 267 | 10 | CID000004680 | |
| Drug | Cinildipine | 4.88e-05 | 56 | 267 | 6 | CID000002752 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 5.39e-05 | 7 | 267 | 3 | CID009547999 | |
| Drug | Br2BAPTA | 5.39e-05 | 7 | 267 | 3 | CID003081001 | |
| Drug | L-quisqualic acid | 5.53e-05 | 180 | 267 | 10 | CID000001209 | |
| Drug | nimodipine | 5.55e-05 | 145 | 267 | 9 | CID000004497 | |
| Drug | Menadione [58-27-5]; Up 200; 23.2uM; PC3; HT_HG-U133A | 5.79e-05 | 181 | 267 | 10 | 4662_UP | |
| Drug | mag-fura-2 | 6.85e-05 | 37 | 267 | 5 | CID000123839 | |
| Drug | Bay K 8644 | 7.22e-05 | 150 | 267 | 9 | CID000002303 | |
| Drug | nilvadipine | 7.24e-05 | 60 | 267 | 6 | CID000004494 | |
| Drug | AC1NBU2S | 7.30e-05 | 117 | 267 | 8 | CID004473765 | |
| Drug | IAA-94 | 7.95e-05 | 61 | 267 | 6 | CID000003667 | |
| Drug | 6-methylpurine-2'-deoxyriboside | 7.95e-05 | 61 | 267 | 6 | CID000097184 | |
| Drug | tetracaine | 7.97e-05 | 88 | 267 | 7 | CID000005411 | |
| Drug | 3-isoreserpine | 8.69e-05 | 190 | 267 | 10 | CID000005052 | |
| Drug | Promazine hydrochloride [53-60-1]; Up 200; 12.4uM; MCF7; HT_HG-U133A | UNC5B ITGA1 SLC30A3 URB1 ICOSLG FAT4 GPR22 PTPN21 BRINP2 ELL | 9.08e-05 | 191 | 267 | 10 | 6028_UP |
| Drug | lercanidipine | 9.54e-05 | 63 | 267 | 6 | CID000065866 | |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; PC3; HT_HG-U133A | 9.90e-05 | 193 | 267 | 10 | 4488_DN | |
| Drug | AC1Q5THZ | PSMB10 ADCY8 PTPN3 SIAE AHR ABHD1 PLD2 NOS1 MGAM NR4A2 CCKAR TG PARP10 MAPK15 TMEM132D ALOXE3 ATP2B1 | 9.92e-05 | 502 | 267 | 17 | CID000001959 |
| Drug | N-methyl-DL-aspartic acid | GABRP DLGAP1 ASIC3 SLC30A3 ADCY8 RYR2 RYR3 ITPR1 CACNG2 PTPN3 PKD1 SCN9A CHRNA10 NOS1 HTR1B GRM6 MAPK15 EIF4G2 CACNG4 ELL | 1.01e-04 | 655 | 267 | 20 | CID000004376 |
| Drug | Betazole hydrochloride; Up 200; 27uM; PC3; HT_HG-U133A | 1.03e-04 | 194 | 267 | 10 | 1812_UP | |
| Drug | Indapamide [26807-65-8]; Down 200; 10.6uM; PC3; HT_HG-U133A | 1.03e-04 | 194 | 267 | 10 | 4335_DN | |
| Drug | Trimeprazine tartrate [4330-99-8]; Down 200; 5.4uM; PC3; HT_HG-U133A | B4GALNT1 ATR GSDMB CAMTA2 ITPR1 TNS2 EML3 CCNE2 CAPN7 TOR1AIP1 | 1.12e-04 | 196 | 267 | 10 | 5881_DN |
| Drug | Nimesulide [51803-78-2]; Down 200; 13uM; MCF7; HT_HG-U133A | PSMB10 HLCS LIN37 SLC35A2 ABTB2 DTNA ARFGEF1 ABCG1 PPP2R3A STAG3 | 1.12e-04 | 196 | 267 | 10 | 7024_DN |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | ABCC3 HLCS ITPR1 COQ8A SLC35A2 TACC1 UTRN PTPN21 FUT9 ALOXE3 | 1.12e-04 | 196 | 267 | 10 | 5236_UP |
| Drug | Levodopa [59-92-7]; Down 200; 20.2uM; PC3; HG-U133A | EPRS1 MAOA PLXNB2 MET OCEL1 GALR3 ARFGEF1 CAPN7 CACNG4 ATP2B1 | 1.12e-04 | 196 | 267 | 10 | 1892_DN |
| Drug | Tolnaftate [2398-96-1]; Up 200; 13uM; MCF7; HT_HG-U133A | DENND4A BRIP1 MAOA NCKAP1 HLCS SLC30A3 JAK3 ICOSLG ARFGEF1 CAPN7 | 1.12e-04 | 196 | 267 | 10 | 4805_UP |
| Drug | Kanamycin A sulfate [25389-94-0]; Up 200; 6.8uM; PC3; HT_HG-U133A | RYR2 NOS1 PDE11A GPR22 WNT2 PTPN21 ORC5 EIF4G2 BRINP2 ALOXE3 | 1.17e-04 | 197 | 267 | 10 | 4625_UP |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 1uM; MCF7; HT_HG-U133A | 1.17e-04 | 197 | 267 | 10 | 4758_UP | |
| Drug | Butylparaben [94-26-8]; Up 200; 20.6uM; HL60; HT_HG-U133A | CEACAM5 SLC30A3 AP1G2 HSPA2 TNS2 TESK1 CCKAR COL18A1 ABCG1 HRH3 | 1.17e-04 | 197 | 267 | 10 | 3069_UP |
| Drug | Isosorbide dinitrate [87-33-2]; Up 200; 17uM; MCF7; HT_HG-U133A | 1.17e-04 | 197 | 267 | 10 | 4742_UP | |
| Drug | Indomethacin [53-86-1]; Down 200; 11.2uM; MCF7; HT_HG-U133A | PSMD11 NR4A2 ARFGEF2 ARFGEF1 PTPN21 EML3 ORC5 PPP2R3A CACNG4 TOR1AIP1 | 1.17e-04 | 197 | 267 | 10 | 5468_DN |
| Drug | Clonidine hydrochloride [4205-91-8]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.22e-04 | 198 | 267 | 10 | 3172_UP | |
| Drug | FLA 365 | 1.27e-04 | 9 | 267 | 3 | CID000072776 | |
| Drug | Isopyrin hydrochloride [18342-39-7]; Up 200; 14.2uM; PC3; HT_HG-U133A | ABCA3 GPR135 UTRN COL3A1 ICOSLG FAT4 PTPN21 EML3 P2RY6 STAG3 | 1.27e-04 | 199 | 267 | 10 | 5879_UP |
| Drug | Moricizine hydrochloride [31883-05-3]; Up 200; 8.6uM; PC3; HT_HG-U133A | ACADSB CHRNA10 COL3A1 FAT4 MAFK DTNA NR4A2 PTPN21 EML3 CACNG4 | 1.27e-04 | 199 | 267 | 10 | 7297_UP |
| Drug | Clonidine hydrochloride [4205-91-8]; Down 200; 15uM; PC3; HT_HG-U133A | GAPVD1 ADGRB2 HLCS ASIC3 CHRNA10 UTRN PTPN21 P2RY6 SLITRK5 ASB1 | 1.27e-04 | 199 | 267 | 10 | 4478_DN |
| Drug | gadolinium | B4GALNT1 RYR2 RYR3 ITPR1 CACNG2 PKD1 KCNK2 ABCD1 CSHL1 CACNG4 | 1.27e-04 | 199 | 267 | 10 | CID000023982 |
| Drug | pimozide | 1.30e-04 | 127 | 267 | 8 | CID000016362 | |
| Drug | polyethylenimine | 1.37e-04 | 128 | 267 | 8 | CID000009033 | |
| Drug | Asp-tyr | 1.37e-04 | 2 | 267 | 2 | CID000152455 | |
| Drug | Vanadates | PRTG GAPVD1 LAMA1 ADGRB2 SLCO4A1 PSMD11 ATP8B1 CPED1 TENM2 MET PTPN3 SIAE SCN9A KCNK2 ADAMTS16 MED12L ABCD1 FBXO32 SIPA1L2 FNIP2 ICOSLG MGAM PTPN21 ADGRG6 TG C2CD3 LGI2 SLFN13 ABCB11 CACNG4 SLFN11 | 1.46e-04 | 1302 | 267 | 31 | ctd:D014638 |
| Drug | isotetrandrine | 1.47e-04 | 97 | 267 | 7 | CID000005422 | |
| Drug | U46619 | NLRP12 GPR182 ADCY8 RYR2 RYR3 ITPR1 CACNG2 PKD1 NOS1 HTR1B ALOXE3 CACNG4 | 1.48e-04 | 285 | 267 | 12 | CID000005618 |
| Drug | Clodronic Acid | MAFG EPRS1 ABCC3 SETX CCDC90B FREM2 AHR SIPA1L2 ARFGEF2 ABCG1 CCNE2 | 1.49e-04 | 243 | 267 | 11 | ctd:D004002 |
| Drug | nitrendipine | 1.57e-04 | 98 | 267 | 7 | CID000004507 | |
| Drug | AC1L2AC7 | 1.59e-04 | 69 | 267 | 6 | CID000068733 | |
| Drug | forskolin from Coleus forskohlii | GABRP GPR182 ASIC3 ADCY8 RYR2 RYR3 ITPR1 PTPN3 LIN37 SCN9A ADAMTS16 AHR PLD2 CHRNA10 NOS1 APPBP2 HTR1B ANPEP GALR3 HCN3 NR4A2 GRM6 TG MAPK15 P2RY6 HRH3 | 1.62e-04 | 1013 | 267 | 26 | CID000003413 |
| Drug | AC1L1KS5 | GPR182 ADCY8 RYR2 RYR3 ITPR1 CACNG2 PKD1 PLD2 NMBR GRM6 MAPK15 CACNG4 ATP2B1 | 1.72e-04 | 334 | 267 | 13 | CID000005631 |
| Drug | valproate | GABRP IER5 ASIC3 LIN9 RYR2 RYR3 ITPR1 CACNG2 SLC35A2 PKD1 SCN9A MAPK15 ADGRE5 CACNG4 | 1.77e-04 | 381 | 267 | 14 | CID000003121 |
| Disease | Intrahepatic Cholestasis | 2.31e-05 | 7 | 260 | 3 | C0008372 | |
| Disease | pancreatic cancer (is_marker_for) | 3.23e-05 | 101 | 260 | 7 | DOID:1793 (is_marker_for) | |
| Disease | taste liking measurement | GAPVD1 MYCBP2 NAB1 TAS2R38 OR2B6 AHR MGAM NR4A2 ABCC5 OR2A5 RFX3 HCRTR2 | 1.88e-04 | 388 | 260 | 12 | EFO_0010155 |
| Disease | double-stranded RNA-binding protein Staufen homolog 2 measurement | 2.31e-04 | 3 | 260 | 2 | EFO_0801547 | |
| Disease | Cholestasis, benign recurrent intrahepatic 1 | 2.31e-04 | 3 | 260 | 2 | C4551899 | |
| Disease | Heterotopia, Periventricular, Autosomal Recessive | 2.31e-04 | 3 | 260 | 2 | C1842563 | |
| Disease | Progressive intrahepatic cholestasis (disorder) | 2.31e-04 | 3 | 260 | 2 | C0268312 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 2.31e-04 | 3 | 260 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | Progressive familial intrahepatic cholestasis type 3 | 2.31e-04 | 3 | 260 | 2 | cv:C1865643 | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 2.31e-04 | 3 | 260 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | GABRP ABCA3 BRIP1 MAOA GSDMB HLCS ATP8B1 TTC3 SLC35A2 AHR PLD2 NMBR PLEKHA8 PLXNB1 DYNC2H1 UBR4 ARFGEF2 TRAPPC8 GRM6 TESK1 SLC39A12 TOR1AIP1 | 2.34e-04 | 1074 | 260 | 22 | C0006142 |
| Disease | alpha fetoprotein measurement | 2.64e-04 | 100 | 260 | 6 | EFO_0010583 | |
| Disease | acute lymphoblastic leukemia | 2.95e-04 | 66 | 260 | 5 | EFO_0000220 | |
| Disease | cortical thickness | PRTG B4GALNT1 MYCBP2 LAMA1 CPED1 TENM2 PI4KA PKD1 KCNK2 TACC1 CLUH FNIP2 GALR3 ARFGEF2 ADAMTS8 AP3M1 TG ORC5 COL18A1 ABCG1 CADPS ELL | 3.81e-04 | 1113 | 260 | 22 | EFO_0004840 |
| Disease | Carcinoma in situ of stomach | 4.20e-04 | 17 | 260 | 3 | C0154060 | |
| Disease | Benign neoplasm of stomach | 4.20e-04 | 17 | 260 | 3 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 4.20e-04 | 17 | 260 | 3 | C0496905 | |
| Disease | Chronic Liver Failure | 4.59e-04 | 4 | 260 | 2 | C2936476 | |
| Disease | Cholestasis, progressive familial intrahepatic 1 | 4.59e-04 | 4 | 260 | 2 | C4551898 | |
| Disease | Juvenile Spinal Muscular Atrophy | 4.59e-04 | 4 | 260 | 2 | C0152109 | |
| Disease | Familial cold autoinflammatory syndrome | 4.59e-04 | 4 | 260 | 2 | cv:C0343068 | |
| Disease | intrahepatic cholestasis (is_implicated_in) | 4.59e-04 | 4 | 260 | 2 | DOID:1852 (is_implicated_in) | |
| Disease | Muscular Atrophy, Spinal, Type II | 4.59e-04 | 4 | 260 | 2 | C0393538 | |
| Disease | Muscular atrophy, spinal, infantile chronic form | 4.59e-04 | 4 | 260 | 2 | C2931358 | |
| Disease | End Stage Liver Disease | 4.59e-04 | 4 | 260 | 2 | C0745744 | |
| Disease | HMN (Hereditary Motor Neuropathy) Proximal Type I | 4.59e-04 | 4 | 260 | 2 | C0043116 | |
| Disease | Unipolar Depression | 5.19e-04 | 259 | 260 | 9 | C0041696 | |
| Disease | Colorectal Carcinoma | ABCC3 ABCA3 LAMA1 BRINP1 ADCY8 MCM3AP NPAP1 DNAH8 COL3A1 CAPN6 NR4A2 ARFGEF1 ABCC5 ABCG1 PANK4 ABCB11 | 5.45e-04 | 702 | 260 | 16 | C0009402 |
| Disease | obesity (implicated_via_orthology) | 6.77e-04 | 215 | 260 | 8 | DOID:9970 (implicated_via_orthology) | |
| Disease | fat body mass | 7.19e-04 | 217 | 260 | 8 | EFO_0005409 | |
| Disease | double-stranded RNA-binding protein Staufen homolog 1 measurement | 7.60e-04 | 5 | 260 | 2 | EFO_0801546 | |
| Disease | 40S ribosomal protein S3a measurement | 7.60e-04 | 5 | 260 | 2 | EFO_0801333 | |
| Disease | polybrominated biphenyl measurement, gestational serum measurement, polybrominated diphenyl ether measurement | 7.60e-04 | 5 | 260 | 2 | EFO_0007961, EFO_0007962, EFO_0007964 | |
| Disease | y-box-binding protein 2 measurement | 7.60e-04 | 5 | 260 | 2 | EFO_0802224 | |
| Disease | lysozyme-like protein 2 measurement | 7.60e-04 | 5 | 260 | 2 | EFO_0801779 | |
| Disease | lung cancer | 8.00e-04 | 21 | 260 | 3 | MONDO_0008903 | |
| Disease | Stomach Carcinoma | 8.00e-04 | 21 | 260 | 3 | C0699791 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 9.14e-04 | 49 | 260 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | 40s ribosomal protein S3 measurement | 1.13e-03 | 6 | 260 | 2 | EFO_0020117 | |
| Disease | 40s ribosomal protein S7 measurement | 1.13e-03 | 6 | 260 | 2 | EFO_0020118 | |
| Disease | pulmonary function measurement, FEV/FEC ratio | 1.23e-03 | 53 | 260 | 4 | EFO_0003892, EFO_0004713 | |
| Disease | Neurodevelopmental Disorders | 1.41e-03 | 93 | 260 | 5 | C1535926 | |
| Disease | pancreatic cancer (biomarker_via_orthology) | 1.58e-03 | 7 | 260 | 2 | DOID:1793 (biomarker_via_orthology) | |
| Disease | acute myocardial infarction (is_marker_for) | 1.58e-03 | 7 | 260 | 2 | DOID:9408 (is_marker_for) | |
| Disease | permanent dental caries | 1.58e-03 | 7 | 260 | 2 | EFO_0600096 | |
| Disease | isolated growth hormone deficiency (implicated_via_orthology) | 1.58e-03 | 7 | 260 | 2 | DOID:0060870 (implicated_via_orthology) | |
| Disease | attention deficit hyperactivity disorder (implicated_via_orthology) | 1.88e-03 | 28 | 260 | 3 | DOID:1094 (implicated_via_orthology) | |
| Disease | mammographic density percentage | 2.09e-03 | 29 | 260 | 3 | EFO_0006502 | |
| Disease | 40S ribosomal protein S4, X isoform measurement | 2.09e-03 | 8 | 260 | 2 | EFO_0801334 | |
| Disease | Cholestasis of pregnancy | 2.09e-03 | 8 | 260 | 2 | C0268318 | |
| Disease | pantothenate measurement | 2.09e-03 | 8 | 260 | 2 | EFO_0021034 | |
| Disease | Pruritus | 2.09e-03 | 8 | 260 | 2 | C0033774 | |
| Disease | Bell's palsy | 2.13e-03 | 102 | 260 | 5 | EFO_0007167 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | GAPVD1 PDE7A UNC5B ADGRB2 GPR135 BRINP1 PSMD11 TENM2 RYR2 MET SIPA1L2 UTRN PDE11A NBEA ZNF654 ELL | 2.13e-03 | 801 | 260 | 16 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | oral squamous cell carcinoma (is_marker_for) | 2.33e-03 | 63 | 260 | 4 | DOID:0050866 (is_marker_for) | |
| Disease | Alcohol abuse | 2.92e-03 | 67 | 260 | 4 | C0085762 | |
| Disease | susceptibility to mononucleosis measurement | 3.25e-03 | 69 | 260 | 4 | EFO_0008403 | |
| Disease | Vasodilators used in cardiac diseases use measurement | 3.31e-03 | 34 | 260 | 3 | EFO_0009926 | |
| Disease | smoking status measurement | DLGAP1 GAPVD1 PDE7A ADGRB2 ADGRB3 BRINP1 SLFN14 TENM2 ADCY8 RYR2 MET KCNK2 MED12L DNAH8 UTRN PDE11A WDR72 GPR22 RFX3 ELL | 3.47e-03 | 1160 | 260 | 20 | EFO_0006527 |
| Disease | lifestyle measurement, alcohol consumption measurement | 3.57e-03 | 115 | 260 | 5 | EFO_0007878, EFO_0010724 | |
| Disease | urate measurement, bone density | GABRP CHAF1B UBE4B ADGRB3 TENM2 ITPR1 ADAMTS16 DNAH8 UTRN AHCTF1 TG EIF4G2 HELZ2 | 3.58e-03 | 619 | 260 | 13 | EFO_0003923, EFO_0004531 |
| Disease | serum alanine aminotransferase measurement, response to combination chemotherapy | 3.60e-03 | 71 | 260 | 4 | EFO_0004735, EFO_0007965 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 3.90e-03 | 36 | 260 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | Congenital Nonbullous Ichthyosiform Erythroderma | 4.04e-03 | 11 | 260 | 2 | C0079154 | |
| Disease | Congenital ichthyosis of skin | 4.04e-03 | 11 | 260 | 2 | cv:C0020758 | |
| Disease | Mental Disorders, Severe | 4.82e-03 | 12 | 260 | 2 | C4046029 | |
| Disease | Diagnosis, Psychiatric | 4.82e-03 | 12 | 260 | 2 | C0376338 | |
| Disease | Behavior Disorders | 4.82e-03 | 12 | 260 | 2 | C0004930 | |
| Disease | Mental disorders | 4.82e-03 | 12 | 260 | 2 | C0004936 | |
| Disease | Neurobehavioral Manifestations | 4.82e-03 | 12 | 260 | 2 | C0525041 | |
| Disease | Inherited neuropathies | 5.25e-03 | 40 | 260 | 3 | C0598589 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 5.47e-03 | 239 | 260 | 7 | EFO_0010934 | |
| Disease | Depression, Neurotic | 5.63e-03 | 41 | 260 | 3 | C0282126 | |
| Disease | Melancholia | 5.63e-03 | 41 | 260 | 3 | C0025193 | |
| Disease | Fulminant Hepatic Failure with Cerebral Edema | 5.66e-03 | 13 | 260 | 2 | C0751197 | |
| Disease | Hepatic Stupor | 5.66e-03 | 13 | 260 | 2 | C0751198 | |
| Disease | Hepatic Encephalopathy | 5.66e-03 | 13 | 260 | 2 | C0019151 | |
| Disease | Hepatic Coma | 5.66e-03 | 13 | 260 | 2 | C0019147 | |
| Disease | icos ligand measurement | 5.66e-03 | 13 | 260 | 2 | EFO_0020460 | |
| Disease | Major Depressive Disorder | 5.98e-03 | 243 | 260 | 7 | C1269683 | |
| Disease | Depressive Syndrome | 6.03e-03 | 42 | 260 | 3 | C0086133 | |
| Disease | gastric ulcer (implicated_via_orthology) | 6.56e-03 | 14 | 260 | 2 | DOID:10808 (implicated_via_orthology) | |
| Disease | Malformations of Cortical Development | 6.56e-03 | 14 | 260 | 2 | C1955869 | |
| Disease | Saldino-Noonan Syndrome | 6.56e-03 | 14 | 260 | 2 | C0036069 | |
| Disease | Cortical Dysplasia | 6.56e-03 | 14 | 260 | 2 | C0431380 | |
| Disease | Intellectual Disability | LAMA1 SLC35A2 MED12L DYNC1H1 WDR62 RARS1 DOCK8 NR4A2 NBEA COL18A1 | 6.63e-03 | 447 | 260 | 10 | C3714756 |
| Disease | melanoma | 6.66e-03 | 248 | 260 | 7 | C0025202 | |
| Disease | diastolic blood pressure, systolic blood pressure | GAPVD1 BRIP1 GPR135 RYR2 MET PIP4K2A WDR62 PDE11A DYNC2H1 ADAMTS8 SLC39A12 C2CD3 ELL | 6.84e-03 | 670 | 260 | 13 | EFO_0006335, EFO_0006336 |
| Disease | glioblastoma (is_marker_for) | 6.86e-03 | 44 | 260 | 3 | DOID:3068 (is_marker_for) | |
| Disease | amino acid measurement | BRIP1 SETX TUBGCP5 RYR2 RYR3 PTPRB FAT4 HTR1B OR8U3 SHOC2 ORC5 BRINP2 HRH3 | 7.52e-03 | 678 | 260 | 13 | EFO_0005134 |
| Disease | triacylglycerol 46:0 measurement | 7.53e-03 | 15 | 260 | 2 | EFO_0010400 | |
| Disease | response to angiotensin-converting enzyme inhibitor, Cough | 7.76e-03 | 46 | 260 | 3 | EFO_0005325, HP_0012735 | |
| Disease | Endogenous depression | 7.76e-03 | 46 | 260 | 3 | C0011573 | |
| Disease | Profound Mental Retardation | 7.90e-03 | 139 | 260 | 5 | C0020796 | |
| Disease | Mental deficiency | 7.90e-03 | 139 | 260 | 5 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 7.90e-03 | 139 | 260 | 5 | C0025363 | |
| Disease | Alzheimer's disease (is_marker_for) | 8.03e-03 | 257 | 260 | 7 | DOID:10652 (is_marker_for) | |
| Disease | phosphatidylcholine 38:6 measurement | 8.56e-03 | 16 | 260 | 2 | EFO_0010388 | |
| Disease | Abnormal behavior | 8.56e-03 | 16 | 260 | 2 | C0233514 | |
| Disease | Autistic Disorder | 8.70e-03 | 261 | 260 | 7 | C0004352 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LNSVERSLSDLFRRY | 681 | O75410 | |
| YANLASVLVLRSVST | 131 | Q8NFU0 | |
| NRFQLVFYLSLSSTR | 496 | Q13075 | |
| VTFTLLLRRRAAAYV | 226 | Q9GZZ6 | |
| RLSVSYLRAKSFFDV | 71 | P35869 | |
| DILRNVTDTFKRATY | 641 | O60241 | |
| IFISYLSDRAQRQAF | 336 | P40145 | |
| YLRDENSSRSFRITI | 361 | Q9Y5Z0 | |
| LVATEASVLVRYFTR | 511 | Q96Q91 | |
| SNAFVIATVYRTRKL | 66 | P28222 | |
| EIFQRSERISLTVAY | 211 | A8MTB9 | |
| RAFESYRARQDSVSL | 36 | P55199 | |
| RSLTILDEQLYSFAF | 21 | Q8TF27 | |
| VDYVTVTFERNRTLS | 311 | Q9H7T0 | |
| SLSIFSEIFQRLYRS | 416 | A4D0V7 | |
| FFETVHIYLRSRTRL | 611 | O60477 | |
| RRAAVNIEFRDLSYS | 71 | P45844 | |
| VREISGFATTYRQLL | 386 | Q00973 | |
| LRTLYRFVTTQARAS | 36 | Q9Y4W6 | |
| RNSLLTDIIAAYQRF | 51 | Q9Y4W6 | |
| AVTDRRSALFQILFA | 1156 | O14514 | |
| EILRNVTDTFKRASY | 621 | O60242 | |
| YSGSIATLERLQSFR | 766 | Q9UP79 | |
| LDARNTKVLTFISYI | 856 | Q86SQ4 | |
| RDAYVQALARFTLLT | 996 | Q9Y6D6 | |
| EKESIAQRSYFRTLL | 201 | Q9Y673 | |
| VSARRSDSVILNVLY | 221 | P06731 | |
| LTLFNVTRNDARAYV | 556 | P06731 | |
| QTLRSLLQEESYRSR | 51 | Q9Y576 | |
| FRSINTRENLYLVTE | 146 | Q8TAX9 | |
| LDFEARRQYSLTVQA | 311 | Q6V0I7 | |
| DDRSLVLTYVFTILN | 761 | P48960 | |
| RDAYVQALARFSLLT | 941 | Q9Y6D5 | |
| SDRNIRYVALTSLLR | 321 | O75843 | |
| RYVALTSLLRLVQSD | 326 | O75843 | |
| IDSLEFQYRILTAAA | 286 | O96020 | |
| RYFADLIAIVSNRFT | 41 | Q5T5M9 | |
| RLVFAVASEDSVLLY | 316 | Q13112 | |
| LSASVLFEYRARRFL | 606 | O94983 | |
| VRFLRSTFTNNLVYD | 121 | Q14406 | |
| AATAYTRLTIFNILS | 1206 | Q99758 | |
| VLFSTTIAENIRYGR | 506 | O95342 | |
| TQLEAARLLTYNAAR | 341 | P45954 | |
| THAVVTARRSLLRYF | 271 | Q96M93 | |
| SYLRAVSEVSINRSL | 406 | O14490 | |
| TAISAVVDNYIRSRR | 16 | Q92624 | |
| LIQAVTRRFSTEYEL | 901 | P15144 | |
| AASSIYINSRSVFLR | 446 | O15484 | |
| RFTLLQGAESIVTYR | 176 | A0A0U1RR11 | |
| SVSTFNLVAISLERY | 126 | P32238 | |
| IFDTFIRDSISRLSN | 2306 | Q96M86 | |
| NFRLISYRVSSQNLV | 256 | Q9Y2T2 | |
| QVSLRSFRQYLEESL | 1016 | Q9P1Z9 | |
| SNKLETIRYLAASVF | 226 | Q9GZT6 | |
| TQIRVVNAFRSSLYE | 1116 | P20020 | |
| RTYNVLAILDFNSDR | 586 | O43520 | |
| VSTSYISVRNALRRY | 781 | Q8TE57 | |
| QFNLEATRTRYSLAT | 426 | Q2M243 | |
| QRSLYREILFLSLVA | 1796 | Q7Z401 | |
| SIDLDNYFTARRLLS | 71 | Q14494 | |
| LSDYRRLSESQLSFR | 611 | Q96PK6 | |
| LLVRLSDVYNRSFLE | 161 | P30039 | |
| RAVIRDLNSLISSDY | 771 | P52333 | |
| VSSERERSRYVAVFQ | 156 | Q9H607 | |
| LEVSERVRTLTQAYF | 536 | Q8IVL6 | |
| FLEFVNYVRSLRVDS | 821 | P26045 | |
| RQRVSLARAVYSDAD | 756 | O15438 | |
| LVSRTFLSVYVARLD | 101 | P33897 | |
| RRFAYLFVNINVTSE | 171 | P21397 | |
| TARATDYLQASAITR | 211 | Q9Y698 | |
| RVLAYLNSRNVAFTI | 71 | Q7RTW8 | |
| TYRDFRLQGVLDSTL | 1296 | Q9ULU8 | |
| YAAERTRFQTLLNEL | 246 | Q86T65 | |
| RSRYVASSELELVNS | 1016 | Q6W4X9 | |
| FYIRRALEILTNATQ | 331 | Q9H4B0 | |
| TNYTVVDFRNRATAL | 91 | Q9H3H1 | |
| AYRISIRAFTQLFDE | 1576 | P23467 | |
| TTQSLIQFVRTVRDY | 1876 | P23467 | |
| SYIFIVAAVLRIRTA | 231 | Q8NGN2 | |
| ISYAFIVRAVLRIQS | 216 | P58173 | |
| VFTLTALSADRYRAI | 131 | P28336 | |
| AASLQYRLTQLDAVR | 656 | Q9BYH8 | |
| RSNTYVIKLFDRSVD | 91 | Q96GY3 | |
| SIEFQRRYATIVLEL | 381 | Q5TKA1 | |
| STRYLREQLAKISDF | 191 | Q86YW9 | |
| SDEFVQSAYLSRRLA | 281 | Q86YW9 | |
| ALRSKYEALQTFART | 106 | O15525 | |
| ALRSKYEALQTFART | 106 | O60675 | |
| FQEYTAGRRLSSLLT | 446 | Q9NPP4 | |
| SSTRFLVFNSRTAEL | 21 | Q14409 | |
| FASYVITDLTQLRKI | 31 | O43187 | |
| RDSVLAASRDYRNII | 1596 | Q14643 | |
| ELFALARQISREVTY | 296 | Q13506 | |
| DTIISIQFLVYRRST | 266 | Q6ZP29 | |
| IQFLVYRRSTAASEL | 271 | Q6ZP29 | |
| DVHVRSIFYQLLRAT | 111 | Q8TD08 | |
| SLSRRSQAIANYALV | 66 | Q8NDA2 | |
| RILFLVAAVTDAYSQ | 6 | A0A0A0MS14 | |
| ETLSTLRYASRAQRV | 346 | Q96FN5 | |
| TRYTLQVNTIARATL | 441 | Q9BYJ1 | |
| AFVNISRTVLQTRYT | 2496 | O43451 | |
| SSFTQRDLRLLKIAY | 381 | Q5SZK8 | |
| LFNLTLTYRRDSDIQ | 151 | Q9Y231 | |
| ALRALNFAYTVSTQR | 881 | O60318 | |
| NRYFTTVCVRLLLES | 1246 | Q14C86 | |
| RLSVEIYDKFQRATS | 346 | O95069 | |
| NLVSFRRTIYLAIQS | 451 | Q9HCG8 | |
| RRTIYLAIQSSLDFE | 456 | Q9HCG8 | |
| SNFRRYEVLREILTT | 356 | P50747 | |
| FLNVTSYSRLANELR | 36 | Q3SXM0 | |
| QRSYSFRVEATNTLI | 331 | Q86UP0 | |
| FYTSITRARFEELNA | 296 | P54652 | |
| LILNEFSYTATEARR | 91 | Q96MA6 | |
| QRTFSARDRAYVASL | 1626 | O43157 | |
| YFTDILRTLLSDLVA | 1651 | O43157 | |
| ALRALSNISLRLFYE | 121 | O15031 | |
| FRDQSTYISAIRERF | 331 | Q9UBU9 | |
| SILATDLTLYFERRT | 771 | Q9HCR9 | |
| TDISRQNEYLSLFRS | 321 | Q13946 | |
| LSSRLQDLYSIVRRA | 1621 | P39060 | |
| TINRYLSFLDGARIS | 91 | Q96JB1 | |
| YFNTVLSLARSLAVQ | 31 | P42356 | |
| SNLSVLRTALRYIQS | 256 | Q99583 | |
| FANTTSLRYLDLRNT | 146 | Q8N7C0 | |
| SIARSIARALNREYF | 531 | P36776 | |
| SLYTLFLESVQSRLR | 591 | Q96RT8 | |
| LSVATFLYQVAERVR | 51 | Q9UHC3 | |
| NNYLIISEDLRSFRS | 106 | A6NLU0 | |
| QIANAAFTSELLYRT | 171 | Q96JA3 | |
| YEEALANRRILLSST | 541 | Q6ZMI0 | |
| LSDLIAARILRYTDF | 456 | Q6NUT2 | |
| TYDLASAVVRIFNLI | 241 | Q9P1Z3 | |
| QYRVTLDSLRQISRS | 721 | P56199 | |
| SYFSSLNLTIRGELR | 1096 | P56199 | |
| VSYFNIVLSILRIRS | 216 | Q8NGG0 | |
| SYLAQFAARAIISEL | 641 | P78344 | |
| YNDQASSSRIIERIF | 926 | Q06190 | |
| FRSLAQEALRDVLSY | 916 | Q9Y2A7 | |
| DRQSTSRILRYLFDN | 2111 | Q7Z442 | |
| TYEVTNRLRSESIAF | 1406 | P29475 | |
| VIAVYFQATSRREAE | 256 | Q8NGR3 | |
| VSYSRILAAILRIQS | 216 | Q96R48 | |
| AVAQRLELREVTYFS | 51 | Q16825 | |
| FAYGTLTVRSLLDTR | 496 | Q9NVE7 | |
| LYRLSFRLSTENSIQ | 551 | Q2VWP7 | |
| ASYSVTEVQLRFARD | 406 | Q9BX63 | |
| SSLENVDSRYRNRAL | 71 | O75144 | |
| QRISLARALYSDRSI | 691 | O15440 | |
| RTVTNYFIVNLSLAD | 86 | O43614 | |
| VRSVDYVLFRSIQRS | 356 | P81408 | |
| FTVSIRNTLLYTLRR | 156 | P36888 | |
| FTLAAVSVDRYLAVR | 111 | O60755 | |
| LRYAFSQLRSTQIAT | 2301 | Q8NCM8 | |
| QFRERSETEYALLRT | 101 | Q5JQS6 | |
| LAVASFRSKAYTRAV | 1641 | Q13535 | |
| AVFRDASRFILNLTS | 91 | A6NJW9 | |
| TYARVLRFFSEVRTA | 316 | Q8IZ08 | |
| SALLTKTNRIYRIFE | 666 | O15303 | |
| EETLRIARIFSSQYS | 2336 | Q4AC94 | |
| AFALKINRYSSAEIR | 11 | Q8NF50 | |
| SFVASLAISAAYERR | 291 | Q9Y6W3 | |
| RFTLLQGAESIVTYR | 176 | P0DPI3 | |
| SSEYLLRIVRASSVF | 96 | Q9UBN1 | |
| VADFRTVLRQYSINL | 1456 | Q5THR3 | |
| TLASQSRYDLAFVVA | 256 | Q9Y6R7 | |
| AVFRDASRFILNLTS | 91 | P10966 | |
| AFILVYSITSRQSLE | 81 | Q96HU8 | |
| RNYTFLLRAAEESTA | 1731 | Q5JV73 | |
| IAESSLRVQFYVSRL | 361 | Q9P278 | |
| SGRYRASVESILIFN | 2041 | O75417 | |
| RFTLLQGAESIVTYR | 176 | A0A0U1RRI6 | |
| GELILTSESSRYQFR | 131 | Q14197 | |
| RSFTDLYIQIIRAAA | 516 | Q8NI60 | |
| SEDLRATLNAFLYRT | 251 | Q5T2N8 | |
| AIRDTFVNASRTLYS | 231 | P05155 | |
| VLISYDRFLSVTRAV | 126 | Q9Y5N1 | |
| DRFLSVTRAVSYRAQ | 131 | Q9Y5N1 | |
| LNVSRLEAVLSTIFY | 76 | Q9Y4J8 | |
| IQFRTDIARTEYLSN | 3541 | Q14204 | |
| DATRRRAFALVSQAY | 111 | Q99627 | |
| RSAVFERVLSAVAAY | 91 | Q5D0E6 | |
| FLRLLSSRASQNITY | 1356 | P02461 | |
| IAYRSSSANRLFRVI | 366 | Q9NQ79 | |
| VVNSITGERLSAYRF | 56 | Q8WYP5 | |
| SRSNLFVLRSGEVVY | 261 | Q32P44 | |
| FADAVELYVQSTTRR | 366 | A6NKP2 | |
| EAAERFTRISQAYVV | 86 | Q96LL9 | |
| FFTDARVLNTVLTRA | 891 | Q9BYK8 | |
| SSSYLAFRISRLEQQ | 326 | Q8IUY3 | |
| VTDRYIFVSLLSRDS | 191 | Q96HH9 | |
| INVFAITLDRYDISV | 131 | Q99680 | |
| TAILDSRRFNYVVRL | 111 | Q969P5 | |
| AIFDTQAIFYRRTTD | 561 | Q9Y6Q1 | |
| YIFSSLNRTNTLRLS | 236 | Q504Y0 | |
| FSILTVRSALFALRY | 4236 | Q92736 | |
| VRSALFALRYNILTL | 4241 | Q92736 | |
| LLTAQQYEIFSRSLR | 576 | Q68D06 | |
| SAIIELSALSVRRQY | 231 | Q6NT55 | |
| RLFSNGTVLYALRIT | 141 | O00591 | |
| IYVIVTRNVFSHRLS | 191 | P48426 | |
| RALTRTAVYTLNLAL | 56 | Q15077 | |
| IVRDLQTARSAFFLV | 3201 | P98161 | |
| AFYDTLDAARSSIRV | 836 | Q53GL7 | |
| TVSRFRKATSILEFY | 151 | P09001 | |
| SAFLELFVLRLAYRS | 441 | P43354 | |
| VSLVLRSARQVYLSD | 36 | Q5VY09 | |
| YRTEFTTALQRVDLF | 416 | P08581 | |
| VENLSIVYRSRDFLV | 6 | Q9UJJ7 | |
| FVARVNYDTTESKLR | 106 | P08621 | |
| FNSALYSLEVRIVAS | 71 | P0DSN6 | |
| RIRTVSYEVRSTFLF | 6 | P59533 | |
| YAFTRIRSIARLANI | 536 | P54136 | |
| SLADLNNVRFSAYRT | 2851 | P46939 | |
| NNYLIISEDLRSFRS | 106 | F8VTS6 | |
| FVRLLTGLYRDTQTS | 81 | Q9Y5M8 | |
| VIFTDVNSILRYLAR | 46 | P07814 | |
| VNSILRYLARVATTA | 51 | P07814 | |
| LRSNLYRRDVTSAIN | 126 | P0C7P3 | |
| LSFVYRTSSVQLRVA | 466 | Q5TGY1 | |
| RNSSLQSRVESFLIY | 71 | Q14C87 | |
| TLYLSLTRFIGDSRV | 431 | Q8N0V4 | |
| ARRIIAQFSKDYETT | 1206 | Q5HYW2 | |
| VAAVSAFAQTLRRYT | 486 | P48380 | |
| VSLDFIRAIARTVNF | 411 | O43913 | |
| LEISRSTFDLLRNSY | 2461 | P25391 | |
| FSRRYLLQNTALEVF | 2216 | Q8NFP9 | |
| RQALEARLVSLYFDT | 126 | O00231 | |
| ELSQSTKRVVLFALY | 46 | O15218 | |
| SNIIASRLYLVARTS | 601 | Q6ZW05 | |
| AAAAAEYTSIRRSRI | 441 | Q15858 | |
| YRVAFRTSELTTLRG | 531 | Q9P2F8 | |
| TTTSERIIAYLRDFN | 1921 | Q7Z333 | |
| LDSLTTLYLRFNRIT | 191 | Q9UQ13 | |
| RELSNTAAYQSVRIL | 141 | Q9HAT2 | |
| LLTAQQYEIFSRSLR | 576 | Q7Z7L1 | |
| RTRRFTNIEFQYSTL | 2661 | Q9NT68 | |
| DLAKRTVFQRSYSVV | 3466 | O75592 | |
| VVELSLRSRGFSSLY | 296 | Q96PL2 | |
| ATVTRILRQTLFRYQ | 116 | P40306 | |
| TLLRRDIVFAASLYT | 1231 | Q15477 | |
| TSYIFIIAAILRIRS | 216 | Q8NH85 | |
| LQSTFVSRKEEYIRF | 836 | Q9NZP6 | |
| LDSVLRYRATVIQAF | 1946 | O60287 | |
| SLNTDFAFRLYRRLV | 46 | Q86WD7 | |
| QNASLILSIRYARTL | 46 | P78381 | |
| NGFINTVITSLERRY | 121 | Q96BD0 | |
| ARTIRQFDERYTSVA | 281 | Q96SE0 | |
| FSQSRYSVVQSLLRD | 756 | Q8N961 | |
| YSVVQSLLRDFSSIR | 761 | Q8N961 | |
| QLAASYFIDRESTLR | 196 | Q9C0B6 | |
| STSFAILLQIYEVQR | 636 | Q7Z7M1 | |
| DRQVSITASTRGFYL | 246 | O75153 | |
| FLLTLFREVAILYRS | 4371 | Q63HN8 | |
| RRYAEFSSALVSINQ | 511 | Q8N1B4 | |
| VQSELFRSRLDSYVR | 121 | Q9Y5R8 | |
| LLRSSRESAFVYAIS | 101 | P09544 | |
| DAYSSFRSVRAIRID | 431 | Q5JTV8 | |
| REETATFALLYRLRN | 236 | Q0ZLH3 | |
| YGNRDLTTRLELFTS | 371 | Q9UJ98 | |
| LTENYIAVVRRTDFL | 416 | O94991 | |
| DSLYGTVRRFLSVVQ | 61 | Q8N271 | |
| RFNDNLVSRSVYIAE | 106 | Q8NDV3 | |
| IILYFSRNALTERSK | 3556 | Q15413 | |
| SYLLSENLSRARISV | 166 | Q86VV4 | |
| VLTVRYSLELTAARF | 456 | Q8TB22 | |
| LAQDERVSRSYLALA | 1076 | O95155 | |
| QTIRFCTYTERLLLV | 216 | Q3MJ13 | |
| LSIFFLERSLEAYRT | 396 | Q8IZM8 | |
| VFRVSLASRAYIKTA | 266 | Q9BTF0 | |
| SSRNFLNEAVDYVIR | 861 | P53804 | |
| REDVISSIRNFLIYV | 21 | Q8N4H5 | |
| SSIRNFLIYVALLRV | 26 | Q8N4H5 | |
| YRALRSAVSSLARVD | 41 | Q15569 | |
| AALLNIRFVYSLRFT | 161 | O75310 | |
| SYSRSAVKRLQLAVF | 686 | Q8IZJ1 | |
| VYILNRDAAARLTIS | 141 | Q15393 | |
| EFVSRLSTQNYFRSL | 421 | Q6ZN44 | |
| EAVLAEASSRLYSRF | 346 | Q99726 | |
| TTFQEALDLYRVLVS | 1421 | O43379 | |
| SYTLRQLDNAVSAFR | 611 | Q9Y2L5 | |
| SYRDLLSANRSAIFL | 36 | Q9NS98 | |
| NTTERLLLSFNYIRT | 46 | O60602 | |
| ATLQLIDTYASFTRA | 1161 | Q5T4S7 | |
| FTETTLYRILQRRFL | 271 | P01266 | |
| FSRALENATRDYFII | 2576 | P01266 | |
| SNATRSLRTLREYVA | 866 | O14939 | |
| LDLTYVTERILAAAF | 131 | Q63HR2 | |
| TYERFSSSLLILQVR | 86 | A0A0B4J234 | |
| ASSLARAYSIVIRQI | 1781 | O95071 | |
| RTQRVFINLLDSYSS | 16 | Q96M32 | |
| VTRLLTEYAFSERSF | 541 | P59046 |